
<!DOCTYPE html>
<html lang="en"     class="pb-page"  data-request-id="92967df4-ed6b-4aff-af45-97ef40c9adb9"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";page:string:Article/Chapter View;ctype:string:Journal Content;requestedJournal:journal:iai;website:website:asmj;article:article:doi\:10.1128/IAI.00206-12;wgroup:string:Publication Websites;pageGroup:string:Publication Pages;subPage:string:Full Text;issue:issue:doi\:10.1128/iai.2012.80.issue-8;journal:journal:iai"/>
<link rel="schema.DC" href="http://purl.org/DC/elements/1.0/"></link><meta name="citation_journal_title" content="Infection and Immunity"></meta><meta name="dc.Title" content="Fine Specificity of Plasmodium vivax Duffy Binding Protein Binding Engagement of the Duffy Antigen on Human Erythrocytes"></meta><meta name="dc.Creator" content="Asim A. Siddiqui"></meta><meta name="dc.Creator" content="Jia Xainli"></meta><meta name="dc.Creator" content="Jesse Schloegel"></meta><meta name="dc.Creator" content="Lenore Carias"></meta><meta name="dc.Creator" content="Francis Ntumngia"></meta><meta name="dc.Creator" content="Menachem Shoham"></meta><meta name="dc.Creator" content="Joanne L. Casey"></meta><meta name="dc.Creator" content="Michael Foley"></meta><meta name="dc.Creator" content="John H. Adams"></meta><meta name="dc.Creator" content="Christopher L. King"></meta><meta name="dc.Description" content="ABSTRACT Plasmodium vivax invasion of human erythrocytes requires interaction of the P. vivax Duffy binding protein (PvDBP) with its host receptor, the Duffy antigen (Fy) on the erythrocyte surface..."></meta><meta name="Description" content="ABSTRACT Plasmodium vivax invasion of human erythrocytes requires interaction of the P. vivax Duffy binding protein (PvDBP) with its host receptor, the Duffy antigen (Fy) on the erythrocyte surface..."></meta><meta name="dc.Publisher" content="&#xA;American Society for Microbiology&#xA;1752 N St., N.W., Washington, DC&#xA;"></meta><meta name="dc.Contributor" content="J. F. UrbanJr."></meta><meta name="dc.Date" scheme="WTN8601" content="2012-5-21"></meta><meta name="dc.Type" content="research-article"></meta><meta name="dc.Format" content="text/HTML"></meta><meta name="dc.Identifier" scheme="publisher-id" content="00206-12"></meta><meta name="dc.Identifier" scheme="doi" content="10.1128/IAI.00206-12"></meta><meta name="dc.Language" content="EN"></meta><meta name="dc.Coverage" content="1752 N St., N.W., Washington, DC"></meta><meta name="dc.Rights" content="Copyright Â© 2012, American Society for Microbiology. All Rights Reserved."></meta><!-- ${citation_fulltext_world_readable:10.1128/IAI.00206-12} -->




<link rel="meta" type="application/atom+xml" href="https://doi.org/10.1128%2FIAI.00206-12"></link>
<link rel="meta" type="application/rdf+json" href="https://doi.org/10.1128%2FIAI.00206-12"></link>
<link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1128%2FIAI.00206-12"></link>



<meta charset="UTF-8">
















        <meta property="og:title" content="Fine Specificity of Plasmodium vivax Duffy Binding Protein Binding Engagement of the Duffy Antigen on Human Erythrocytes | Infection and Immunity"/>
    


        <meta property="og:type" content="Article"/>
    


        <meta property="og:url" content="https://journals.asm.org/doi/abs/10.1128/IAI.00206-12"/>
    

        <meta property="og:image" content="https://journals.asm.org/cms/asset/4be65bbe-8f41-4bf8-96a0-be5b51aae56f/iai.2012.80.issue-8.cover.gif" />
        <meta property="og:image:width" content="113" />
        <meta property="og:image:height" content="150" />
    


        <meta property="og:site_name" content="Infection and Immunity"/>
    


        <meta property="og:description" content="Plasmodium vivax invasion of human erythrocytes requires interaction of the P. vivax Duffy binding protein (PvDBP) with its host receptor, the Duffy antigen (Fy) on the
erythrocyte surface. Consequently, PvDBP is a leading vaccine candidate. The ..."/>
    
<meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=1, user-scalable=0"/>
<title>Fine Specificity of Plasmodium vivax Duffy Binding Protein Binding Engagement of the Duffy Antigen on Human Erythrocytes | Infection and Immunity</title>










            <link rel="stylesheet" type="text/css" href="/wro/l0of~article-metrics-phase3.css">
        
<link rel="stylesheet" type="text/css" href="/wro/l0of~product.css">



    
    
                <link rel="stylesheet" href="/products/asmj/releasedAssets/css/build-6742698955b5929bab3a.css" media="all" id="build-style-sheet">
                <script>
                    function isIE() { //won't check for edge browser
                        var ua = navigator.userAgent;
                        /* MSIE used to detect old browsers and Trident used to newer ones*/
                        var is_ie = ua.indexOf("MSIE ") > -1 || ua.indexOf("Trident/") > -1;
          
                        return is_ie; 
                    }
                    
                    if(isIE()) {
                        document.write('<link rel="stylesheet" href="/products/asmj/releasedAssets/css/build-style-fallback-0e2f8eb0a5d072bb5fa3.css" media="all" />')
                        var buildCss = document.getElementById('build-style-sheet');
                        buildCss.parentNode.removeChild(buildCss);
                    }
                </script>
        <link rel="stylesheet" href="/products/asmj/releasedAssets/css/print-6742698955b5929bab3a.css"media="print">
    
        <script>
        try {
            document.documentElement.classList.add('js');
        } catch (e) {
        }
    </script>
     
    





<meta http-equiv="X-UA-Compatible" content="IE=edge">
<style>
:root{
	--journal-image: url('/pb-assets/images/Homepage Header Images/header-iai-desktop-1602282256940.png');
	--journal-mobile-image: url("/pb-assets/images/Homepage Header Images/header-iai-mobile-1605057095637.png");
	--landing-image: url("/pb-assets/images/Homepage Header Images/header-global-desktop-1603901826210.png");
	--landing-mobile-image: url("/pb-assets/images/Homepage Header Images/header-global-mobile-1605057223667.png");


}
</style>
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/Journals-Atypon-1641917642317.css">
<script async src="https://securepubads.g.doubleclick.net/tag/js/gpt.js"></script>
<script>
	window.googletag = window.googletag || {cmd: []};
	googletag.cmd.push(function() {
    	googletag.defineSlot('/13678947/asm_leader-mob', [[728, 90], [320, 50]], 'div-gpt-ad-1594664599282-0').addService(googletag.pubads());
    	googletag.defineSlot('/13678947/asm_box', [300, 250], 'div-gpt-ad-1594664702378-0').addService(googletag.pubads());	
		googletag.pubads().enableSingleRequest();
		
			
				googletag.pubads().setTargeting('asmjournals', 'iai');
			
		
		googletag.enableServices();
	});
</script>



                    <link rel="canonical" href="https://journals.asm.org/doi/10.1128/IAI.00206-12">
                





    <script src="//scholar.google.com/scholar_js/casa.js" async></script>








    
    

    
    
    
            <script type="text/javascript" src="/wro/l0of~article-metrics-phase2.js"></script>
        


    <!-- Google Tag Manager -->
    













<script>
    var dataLayer = dataLayer ||[];
    
    dataLayer.push({"event":"pageview","page_domain":"journals.asm.org","page_path":"/doi/10.1128/IAI.00206-12","page_name":"Fine Specificity of Plasmodium vivax Duffy Binding Protein Binding Engagement of the Duffy Antigen on Human Erythrocytes | Infection and Immunity","page_type":"article","article_title":"Fine Specificity of Plasmodium vivax Duffy Binding Protein Binding Engagement of the Duffy Antigen on Human Erythrocytes","article_type":"Research Article","article_category":"Fungal and Parasitic Infections","article_doi":"10.1128/IAI.00206-12","article_access":"free","article_received_date":"25 February 2012","article_accepted_date":"11 May 2012","article_published_online_date":"18 July 2012","article_issue":"volume 80, issue 8","article_issue_date":"August 2012","journal":"Infection and Immunity","user_type":"Guest","basic_groups":["All users group","Unknown Users","All users no webcrawlers"],"smart_groups":["Institution- IP authentication"]});
    
</script>


    <script>(function(w,d,s,l,i){w[l]=w[l]||[];w[l].push({'gtm.start':new Date().getTime(),event:'gtm.js'});var f=d.getElementsByTagName(s)[0],j=d.createElement(s),dl=l!='dataLayer'?'&l='+l:'';j.async=true;j.src='https://www.googletagmanager.com/gtm.js?id='+i+dl;f.parentNode.insertBefore(j,f);})(window,document,'script','dataLayer','GTM-MTLLM76');</script>
    <!-- End Google Tag Manager -->

</head>
<body class="pb-ui">


    <!-- Google Tag Manager (noscript) -->
    <noscript><iframe src="https://www.googletagmanager.com/ns.html?id=GTM-MTLLM76" height="0" width="0" style="display:none;visibility:hidden"></iframe></noscript>
    <!-- End Google Tag Manager (noscript) -->




















<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>





    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">




        
        <div>



        
        




<div class="popup top-drawer request-username-drawer username-popup hidden">
    <div class="content">
        <a href="#" class="close"><i class="icon-close_thin"></i></a>
        <h2>Request Username</h2>
        <div class="form">
            <p>Can't sign in? Forgot your username?</p>
            <p class="sub">Enter your email address below and we will send you your username</p>
            <div class="message error"></div>
            <form action="/action/requestUsername" method="post"><input type="hidden" name="requestUsername" value="requestUsername" />
                <div class="input-group">
                    <div class="label">
                        <label for="5a26c991-102b-4ded-a542-61c81c149bd5.email">Email*</label>
                    </div>
                    <input id="5a26c991-102b-4ded-a542-61c81c149bd5.email" class="email" type="text" name="email" value="" size="15" />
                </div>
                
                    <div class="username-recaptcha-ajax"></div>
                
                <input class="button primary submit" type="submit" name="submit" value="Submit" disabled="disabled" />
                <div class="center">
                    <a href="#" class="cancel">Close</a>
                </div></form>
        </div>
        <div class="success-template hidden note">
            <p>If the address matches an existing account you will receive an email with instructions to retrieve your username</p>
        </div>
    </div>
</div>




        
        





<div class="popup registration-popup hidden">
    <div class="content">
        <a href="#" class="close"><i class="icon-close_thin"></i></a>
        <h2>Create a new account</h2>
        <form action="/action/registration" class="registration-form" method="post"><input type="hidden" name="redirectUri" value="/doi/10.1128/IAI.00206-12" />
            <div class="input-group">
                <div class="label">
                    <label for="68b11fd0-c69c-4e98-9f68-782a66b3c94a.email">Email</label>
                </div>
                <input id="68b11fd0-c69c-4e98-9f68-782a66b3c94a.email" class="email" type="email" name="email" value="" />
            </div>
            <div class="submit">
                <input class="button submit primary" type="submit" value="Register" />
            </div></form>
        <div class="center">
            <a href="/action/showLogin" class="show-login">
                
                Returning user
            </a>
        </div>
    </div>
</div>




        
        



<div class="popup change-password-drawer hidden">
    <div class="content">
        <a href="#" class="close cancel"><i class="icon-close_thin"></i></a>
        <div class="form legacy-form">
            






<h2>Change Password </h2>
<form action="/action/changePassword" method="post"><div class="message error"></div>
    <input type="hidden" name="submit" value="submit" />
    <div class="input-group">
        <div class="label">
            <label for="2671405c-5390-4992-8d19-1189df090272-old">Old Password</label>
        </div>
        <input id="2671405c-5390-4992-8d19-1189df090272-old" class="old" type="password" name="old" value="" autocomplete="off" />
        <span class="password-eye-icon icon-eye hidden"></span>
    </div>
    <div class="input-group">
        <div class="label">
            <label for="2671405c-5390-4992-8d19-1189df090272-new">New Password</label>
        </div>
        <input id="2671405c-5390-4992-8d19-1189df090272-new" class="pass-hint new" type="password" name="new" value="" autocomplete="off" />
        <span class="password-eye-icon icon-eye hidden"></span>
        
            







    


    


    


<div class="password-strength-indicator" data-min="8" data-max="20" data-strength="3">
    <span class="text too-short">Too Short</span>
    <span class="text weak">Weak</span>
    <span class="text medium">Medium</span>
    <span class="text strong">Strong</span>
    <span class="text very-strong">Very Strong</span>
    <span class="text too-long">Too Long</span>
</div>
        
    </div>
    <input class="button primary submit" type="submit" value="Submit" disabled="disabled" /></form>
        </div>
        <div class="success-template hidden">
            <h2>Password Changed Successfully</h2>
            <p>Your password has been changed</p>
        </div>
    </div>
</div>





        
        















<div class="popup login-popup hidden">
    <div class="content">
        <a href="#" class="close"><i class="icon-close_thin"></i></a>
        

        <div class="login-form-container ">
            <div class="tab tab--flex">
                <ul class="rlist tab__nav" role="tablist">
                    <li class="active" role="presentation">
                        <a class="active " id="pane-m1x01con" href="#pane-m1x01" aria-controls="pane-m1x01" role="tab"
                           data-toggle="tab" title="login" aria-selected="true" data-simple-tab-id=""
                           aria-expanded="true">
                            <span>Login</span>
                        </a>
                    </li>
                    <li role="presentation">
                        <a id="pane-m1x11con" href="#pane-m1x11" aria-controls="pane-m1x11" role="tab"
                           data-toggle="tab" title="register" aria-selected="false">
                            <span>Register</span>
                        </a>
                    </li>
                </ul>
                <ul class="rlist tab__content">
                    <li class="tab__pane active" id="pane-m1x01" aria-labelledby="pane-m1x01con" role="tabpanel">
                        




























<div class="login-form">
    
    <form action="/action/doLogin" method="post"><input type="hidden" name="id" value="016a54f6-925d-4632-a5f6-22977f0dce11" />
        





        <input type="hidden" name="redirectUri" value="/doi/10.1128/IAI.00206-12" />
    

<input type="hidden" name="loginUri" value="/doi/10.1128/IAI.00206-12" />
        
            <input type="hidden" name="popup" value="true" />
        
        
                

























    
        
    
    
        
    
    
    
        
    

        

        
    <div class="input-group">
        <div class="label ">

            
                    <label for="login">Email*</label>
                
            
        </div>
        
        
            
            
                
            
        
        <div class="iconable__input"><input id="login" class="login" type="text" name="login" value="" size="15" placeholder="Enter your email address" /><div class="icon-mail"></div></div>
        
                    <div class="actions">
                        
                    </div>
                
    </div>

                





















    



    
    
    <div class="input-group">
        <div class="label ">
            <label for="password">Password*</label>
            
        </div>
        
        
            
            
                
            
        
        <div class="iconable__input"><input id="password" class="password" type="password" name="password" value="" autocomplete="off" placeholder="Enter your password" /><div class="icon-lock"></div></div>
        <span class="password-eye-icon icon-eye hidden"></span>
        
                    <div class="actions reset-password">
                        
                        
                        <i class="icon-lock"></i>
                        <span>
                            Forgot password?
                            Reset it <a href="/action/requestResetPassword" class="link show-request-reset-password uppercase styled-link">here</a>
                        </span>
                    </div>
                
    </div>

            

        

        <div class="remember">
            <label class="checkbox--primary remember-me" for="016a54f6-925d-4632-a5f6-22977f0dce11-remember">
                <input id="016a54f6-925d-4632-a5f6-22977f0dce11-remember" class="cmn-toggle cmn-toggle-round-flat" type="checkbox" name="remember" value="true" />
                <span class="label-txt">Keep me logged in</span>
            </label>
        </div>
        
                <div class="submit-section">
                    <input class="button submit primary" type="submit" name="submit" value="Login" />
                    <span class="required-info">Fields with * are mandatory</span>
                </div>
            
        

























        

        <div class="login-tabs-footer">
            <div class="actions">
                
                
                <span>
                    Don&apos;t have an account? Create one <a href="/action/registration" class="uppercase styled-link">here</a>
                </span>
            </div>
        </div></form>
</div>
                    </li>
                    <li class="tab__pane" id="pane-m1x11" aria-labelledby="pane-m1x11con" role="tabpanel">
                        <form action="/action/registration" class="registration-form" method="post"><input type="hidden" name="redirectUri" value="/doi/10.1128/IAI.00206-12" />
                            <div class="input-group">
                                <div class="label">
                                    <label for="016a54f6-925d-4632-a5f6-22977f0dce11.email">Email*</label>
                                </div>
                                <div class="iconable__input">
                                    <input id="016a54f6-925d-4632-a5f6-22977f0dce11.email" class="email" type="email" name="email" value="" placeholder="Enter your email address" />
                                    <div class="icon-mail"></div>
                                </div>
                            </div>
                            <div class="submit-section">
                                <input class="button submit primary" type="submit" value="Register" />
                                <span class="required-info">Fields with * are mandatory</span>
                            </div>
                            <div class="login-tabs-footer">
                                <div class="actions">
                                    
                                    
                                    <span>
                                        Already have an account? Login <a href="/action/showLogin" class="uppercase styled-link">here</a>
                                    </span>
                                </div>
                            </div></form>
                    </li>
                </ul>
            </div>
        </div>
    </div>
</div>




        
        



<div class="popup top-drawer request-reset-password-drawer hidden">
    <div class="content">
        <a href="#" class="close" tabindex="0"><i class="icon-close_thin"></i></a>
        <div class="form">
            





<p>Can't sign in? Forgot your password?</p>
<p class="sub">Enter your email address below and we will send you the reset instructions</p>
<div class="message error"></div>
<form action="/action/requestResetPassword" class="request-reset-password-form" method="post"><input type="hidden" name="requestResetPassword" value="true" />
    
    <div class="input-group">
        <div class="label">
            <label for="7660a830-973e-446c-89b4-6e6ce315b3e0.email">Email*</label>
        </div>
        <input id="7660a830-973e-446c-89b4-6e6ce315b3e0.email" class="email" type="text" name="email" value="" size="15" />
    </div>
    
        








    

    
    
    
    

    
            <div class="clearfix"></div>
<div class="label required">
    <label for="captchaCode" class="prompt" style="white-space: nowrap">Retype the code from the picture:</label>
</div>
<link type="text/css" rel="stylesheet" href="/botdetectcaptcha?get=layoutStyleSheet" />

<div class="LBD_CaptchaDiv" id="sampleCaptcha" style="width: 280px !important; height: 50px !important"><!--
   --><div class="LBD_CaptchaImageDiv" id="sampleCaptcha_CaptchaImageDiv" style="width: 250px !important; height: 50px !important"><!--
   --><a target="_blank" href="http://captcha.com/java-captcha-info.html" onclick="sampleCaptcha.OnHelpLinkClick(); return sampleCaptcha.FollowHelpLink;"><img class="LBD_CaptchaImage" id="sampleCaptcha_CaptchaImage" src="/botdetectcaptcha?get=image&amp;c=sampleCaptcha&amp;t=6c6d808a20424e0c9dec62853a3a8f06" alt="CAPTCHA" /></a></div><!--
   --><div class="LBD_CaptchaIconsDiv" id="sampleCaptcha_CaptchaIconsDiv" style="width: 24px !important;"><!--
   --><a class="LBD_ReloadLink" id="sampleCaptcha_ReloadLink" href="#" onclick="sampleCaptcha.ReloadImage(); this.blur(); return false;" title="Change the CAPTCHA code"> <img class="LBD_ReloadIcon" id="sampleCaptcha_ReloadIcon" src="/botdetectcaptcha?get=ReloadIcon" alt="Change the CAPTCHA code" /></a><!--
   --><a id="sampleCaptcha_SoundLink" class="LBD_SoundLink" href="/botdetectcaptcha?get=sound&amp;c=sampleCaptcha&amp;t=6c6d808a20424e0c9dec62853a3a8f06" onclick="sampleCaptcha.PlaySound(); this.blur(); return false;" title="Speak the CAPTCHA code"> <img class="LBD_SoundIcon" id="sampleCaptcha_SoundIcon" src="/botdetectcaptcha?get=SoundIcon" alt="Speak the CAPTCHA code" /></a><!--
   --><div class="LBD_Placeholder" id="sampleCaptcha_AudioPlaceholder">&nbsp;</div><!--
   --></div>

<script type="text/javascript" src="/botdetectcaptcha?get=clientScriptInclude"></script>
<script type="text/javascript">
    //<![CDATA[
     BotDetect.Init('sampleCaptcha', '6c6d808a20424e0c9dec62853a3a8f06', 'captchaCode', true, true, true, true, 1200, 7200, 0);
    //]]>
    </script>


<script type="text/javascript">
    //<![CDATA[
      try{(function(){var bdrsn = document.createElement('script'); bdrsn.type = 'text/javascript'; bdrsn.async = true; bdrsn.src = document.location.protocol + '//remote.captcha.com/include.js?i=ATABMwExATMBMAJBMhMRP3E_PygHKT8_Pz9AbXw_Yj8i'; var fsn = document.getElementsByTagName('script')[0]; fsn.parentNode.insertBefore(bdrsn, fsn);})();} catch(err){}
    //]]>
    </script>

   <input type="hidden" id="LBD_VCID_sampleCaptcha" name="LBD_VCID_sampleCaptcha" value="6c6d808a20424e0c9dec62853a3a8f06" />
</div>

<input type="hidden" value="0" id="LBD_BackWorkaround_sampleCaptcha">
<div class="validationDiv">
    <input type="hidden" name="loginBotCaptcha" value="">
    <input id="captchaCode" type="text" name="captchaCode"/>
</div>
        

    

    

    
    <input class="button primary submit" type="submit" name="submit" value="Submit" disabled="disabled" /></form>
            
            <div class="center">
                <a href="#" class="cancel">Cancel</a>
            </div>
        </div>
        <div class="success-template hidden">
            <p>If the address matches an existing account you will receive an email with instructions to reset your password.</p>
            <div class="center">
                <a href="#" class="cancel">Close</a>
            </div>
        </div>
    </div>
</div>




        
        




<div class="top-drawer verify-phone-drawer hidden">
    <div class="content">
        <div class="form">
            <h2>Verify Phone</h2>
            <form action="/action/verifyPhoneNumber" method="post"><input type="hidden" name="submit" value="submit" />
                <div class="message error"></div>
                <div class="input-group">
                    <div class="label">
                        <label for="6f5823be-1bcb-45d4-9e6e-3734bacc9f87-code">Enter the verification code</label>
                    </div>
                    <input id="6f5823be-1bcb-45d4-9e6e-3734bacc9f87-code" class="verificationCode" type="text" name="verificationCode" value="" size="15" />
                </div>
                <input class="button primary submit" type="submit" value="Submit" disabled="disabled" /></form>
            <div class="center">
                <a href="#" class="cancel">Cancel</a>
            </div>
        </div>
        <div class="success-template hidden">
            <h2>Congrats!</h2>
            <p>Your Phone has been verified</p>
            <div class="center">
                <a href="/action/showPreferences" class="button primary submit">close</a>
            </div>
        </div>
    </div>
</div>





        
        <div id="search-overlay" class="header__search-overlay search-overlay js--hidden"><div class="search-overlay__close"><a href="#" title="Close search panel" data-hide-target-id="search-overlay" class="search-overlay__close__btn"><span>CLOSE </span><i class="icon-close"></i></a></div><div class="container">



        
        <div class="quick-search quick-search--all"><div class="full-width quickSearchFormContainer"><div class="tab"><div class="quick-search__searchbox"><ul role="tablist" class="rlist tab__nav dropblock--tab"><li role="presentation" class="tab__nav__item active"><a href="#pane-2037e191-2746-4af8-ae16-bb4d0b3856910" aria-controls="pane-0" role="tab" data-toggle="tab" title="This Journal" id="pane-2037e191-2746-4af8-ae16-bb4d0b3856910-con" aria-expanded="false" class="tab__nav__item__link">This Journal</a></li><li role="presentation" class="tab__nav__item"><a href="#pane-2037e191-2746-4af8-ae16-bb4d0b3856911" aria-controls="pane-1" role="tab" data-toggle="tab" title="Anywhere" id="pane-2037e191-2746-4af8-ae16-bb4d0b3856911-con" aria-expanded="false" class="tab__nav__item__link">Anywhere</a></li></ul><div class="quick-search__search-items tab__content"><div id="pane-2037e191-2746-4af8-ae16-bb4d0b3856910" aria-labelledby="pane-2037e191-2746-4af8-ae16-bb4d0b3856910-con" role="tabpanel" class="tab__pane quick-search-pane__anywhere"><form action="/action/doSearch" name="thisJournalQuickSearch" method="get" class="quick-search__form"><div class="quick-search__input input-group option-0 option-journal"><label for="AllField2037e191-2746-4af8-ae16-bb4d0b3856910" class="sr-only">Enter words / phrases / DOI / ISBN / keywords / authors / etc</label><input autocomplete="off" type="search" id="AllField2037e191-2746-4af8-ae16-bb4d0b3856910" name="AllField" aria-label="Enter words / phrases / DOI / ISBN / keywords / authors / etc" placeholder="Search here within this Journal" data-display-labels="true" data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" class="autocomplete"/><input type="hidden" name="SeriesKey" value="iai"/></div><button id="quick-search-btn" type="submit" title="Search" class="btn btn-primary btn--borderless quick-search__button"><span class="sr-only">Search</span><i aria-hidden="true" class="icon-search"></i><span>Search</span></button></form></div><div id="pane-2037e191-2746-4af8-ae16-bb4d0b3856911" aria-labelledby="pane-2037e191-2746-4af8-ae16-bb4d0b3856911-con" role="tabpanel" class="tab__pane quick-search-pane__anywhere"><form action="/action/doSearch" name="defaultQuickSearch" method="get" class="quick-search__form"><div class="quick-search__input input-group option-1 "><label for="AllField2037e191-2746-4af8-ae16-bb4d0b3856911" class="sr-only">Enter words / phrases / DOI / ISBN / keywords / authors / etc</label><input autocomplete="off" type="search" id="AllField2037e191-2746-4af8-ae16-bb4d0b3856911" name="AllField" aria-label="Enter words / phrases / DOI / ISBN / keywords / authors / etc" placeholder="Enter words / phrases / DOI / ISBN / keywords / authors / etc" data-display-labels="true" data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" class="autocomplete"/></div><button id="quick-search-btn" type="submit" title="Search" class="btn btn-primary btn--borderless quick-search__button"><span class="sr-only">Search</span><i aria-hidden="true" class="icon-search"></i><span>Search</span></button></form></div>



        
        <div class="quick-search__links">
    <a href="/search/advanced" class="quick-search__advanced-link">Advanced search</a>
</div>
</div></div></div></div></div>
<div class="search-overlay__autocomplete"><div id="autocompleted-terms"></div></div><div class="search-overlay__suggestions"><div class="search-overlay__suggestions__title">Suggested Terms:</div><ul class="rlist search-overlay__suggestions__list">



        
        <li><a href="/asm-author-center" class="btn btn-secondary">author information</a></li>
<li><a href="/migration-information" class="btn btn-secondary">migration information</a></li>
<li><a href="/publication-fees" class="btn btn-secondary">publication fees</a></li>
<li><a href="/asm-covid-19" class="btn btn-secondary">COVID-19 collection</a></li>
<li><a href="/collection" class="btn btn-secondary">asm journals collections</a></li>
</ul></div></div></div><header class="header header--journal header--journal-page"><div class="header__row-1">



        
        <div class="journals-menu">
	<a data-toggle-target-id="journals-menu-content" href="#" title="Journals Menu" class="journals-menu__trigger js--target-hidden">
		<i class="icon-dehaze"></i>
		<i class="icon-close"></i>
	</a>
	<div id="journals-menu-content" class="journals-menu__content js--hidden" aria-expanded="true">
		<a href="#" data-hide-target-id="journals-menu-content" class="journals-menu__back">
			<i class="icon-arrow_left"></i>
			<span>BACK</span>
		</a>
		<ul class="rlist journals-menu__list">
			<li><a href="/journal/aac"><img src="/pb-assets/images/thumbnails/thumb-aac-1602006917653.jpg" alt="Antimicrobial Agents and Chemotherapy"><span>Antimicrobial Agents and Chemotherapy</span></a></li>
			<li><a href="/journal/aem"><img src="/pb-assets/images/thumbnails/thumb-aem-1602006917677.jpg" alt="Applied and Environmental Microbiology"><span>Applied and Environmental Microbiology</span></a></li>
			<li><a href="/journal/cvi"><img src="/pb-assets/images/thumbnails/thumb-cvi-1602006922190.jpg" alt="Clinical and Vaccine Immunology"><span>Clinical and Vaccine Immunology</span></a></li>
			<li><a href="/journal/cmr"><img src="/pb-assets/images/thumbnails/thumb-cmr-1602006918000.jpg" alt="Clinical Microbiology Reviews"><span>Clinical Microbiology Reviews</span></a></li>
			<li><a href="/journal/ecosalplus"><img src="/pb-assets/images/thumbnails/thumb-ecosalplus-1602678711627.jpg" alt="EcoSal Plus"><span>EcoSal Plus</span></a></li>
			<li><a href="/journal/ec"><img src="/pb-assets/images/thumbnails/thumb-ec-1602006922537.jpg" alt="Eukaryotic Cell"><span>Eukaryotic Cell</span></a></li>
			<li><a href="/journal/iai"><img src="/pb-assets/images/thumbnails/thumb-iai-1602006922193.jpg" alt="Infection and Immunity"><span>Infection and Immunity</span></a></li>
			<li><a href="/journal/jb"><img src="/pb-assets/images/thumbnails/thumb-jb-1602006930407.jpg" alt="Journal of Bacteriology"><span>Journal of Bacteriology</span></a></li>
			<li><a href="/journal/jcm"><img src="/pb-assets/images/thumbnails/thumb-jcm-1602006930870.jpg" alt="Journal of Clinical Microbiology"><span>Journal of Clinical Microbiology</span></a></li>
			<li><a href="/journal/jmbe"><img src="/pb-assets/images/thumbnails/thumb-jmbe-1606273579503.jpg" alt="Journal of Microbiology &amp; Biology Education"><span>Journal of Microbiology &amp; Biology Education</span></a></li>
			<li><a href="/journal/jvi"><img src="/pb-assets/images/thumbnails/thumb-jvi-1602006937397.jpg" alt="Journal of Virology"><span>Journal of Virology</span></a></li>
			<li><a href="/journal/mbio"><img src="/pb-assets/images/thumbnails/thumb-mbio-1602006937397.jpg" alt="mBio"><span>mBio</span></a></li>
			<li><a href="/journal/mmbr"><img src="/pb-assets/images/thumbnails/thumb-mmbr-1602006945363.jpg" alt="Microbiology and Molecular Biology Reviews"><span>Microbiology and Molecular Biology Reviews</span></a></li>
			<li><a href="/journal/mra"><img src="/pb-assets/images/thumbnails/thumb-mra-1602006946427.jpg" alt="Microbiology Resource Announcements"><span>Microbiology Resource Announcements</span></a></li>
			<li><a href="/journal/spectrum"><img src="/pb-assets/images/thumbnails/thumb-spectrum-1602006955410.jpg" alt="Microbiology Spectrum"><span>Microbiology Spectrum</span></a></li>
			<li><a href="/journal/mcb"><img src="/pb-assets/images/thumbnails/thumb-mcb-1602006937413.jpg" alt="Molecular and Cellular Biology"><span>Molecular and Cellular Biology</span></a></li>
			<li><a href="/journal/msphere"><img src="/pb-assets/images/thumbnails/thumb-msphere-1602006946427.jpg" alt="mSphere"><span>mSphere</span></a></li>
			<li><a href="/journal/msystems"><img src="/pb-assets/images/thumbnails/thumb-msystems-1602006955407.jpg" alt="mSystems"><span>mSystems</span></a></li>
		</ul>
	</div>
</div>
<div class="header__logos">



        
        <a href="https://asm.org/" title=""><img id="" alt="" src="/specs/products/asmj/releasedAssets/images/asm-white.svg"/></a>




        
        <a href="/" title=""><img id="" alt="" src="/specs/products/asmj/releasedAssets/images/asm-logotype.svg"/></a>
</div><div data-truncate="1" class="header__feed mx-3 js--truncate"></div><div class="header__attribution"></div><div class="header__cart">



        
        















<div class="eCommerceCartIndicatorWidget">
    
            <a href="/action/showCart?FlowID=1&amp;aria-label=Shopping+Cart" id="cartLabel" class="quick-menu__item" aria-label="Shopping Cart">
                <div class="cartLabel" title="Cart">
                    <i class="icon-shopping_cart" aria-hidden="true"></i>
                    <span class="filter-count filter-count-bubble shopping-cart hidden"
                          data-id="cart-size">0</span>
                        
                </div>
            </a>
        
</div>
</div><div class="header__login">



        
        




    








        




    













<div class="user-login-bar">
    <div title="Sign in" class="loginBar user-login-bar">
        <div class="user-login-bar">
            <div class="loginBar">
                <div class="loginBar__login">
                    <a href="/action/showLogin?redirectUri=%2Fdoi%2F10.1128%2FIAI.00206-12&amp;data-toggle-target-id=loginOptions" class="btn btn-primary btn--light btn--darker-content btn--borderless" redirectUri="/doi/10.1128/IAI.00206-12" data-toggle-target-id="loginOptions">
                        Login
                    </a>
                    <div id="loginOptions" class="loginBar__login__options">
                        <a href="/action/ssostart?idp=https%3A%2F%2Flogin.asm.org%2Fidp%2Fshibboleth&amp;redirectUri=%2Fdoi%2F10.1128%2FIAI.00206-12">
                            
                            <img src="/specs/products/asmj/releasedAssets/images/logo-textless.svg" class="mr-2">
                            <span>ASM Member Login</span>
                            <i class="icon-open_in_new" aria-hidden="true"></i>
                        </a>
                        <a href="/action/showLogin?redirectUri=%2Fdoi%2F10.1128%2FIAI.00206-12">
                            <i class="ml-1 mr-2 icon-account_circle"></i>
                            Non-Member Login
                        </a>
                        <a href="/action/ssostart?redirectUri=%2Fdoi%2F10.1128%2FIAI.00206-12">
                            <i class="ml-1 mr-2 icon-institution"></i>
                            Institutional Login
                        </a>
                        <a href="/action/registration?redirectUri=%2Fdoi%2F10.1128%2FIAI.00206-12" class="btn btn-secondary btn--inverse btn--borderless btn--darker-content btn-register" title="Register">
                            Register
                        </a>
                    </div>
                </div>
            </div>
        </div>
    </div>
</div>



    

</div>



        
        <a href="#" data-show-target-id="search-overlay" class="hidden-md hidden-sm hidden-xs search-trigger js--target-shown"><i title="Open Search Panel" class="icon-search"></i></a>
</div><div class="header__row-2"><a data-toggle-target-id="responsive-menu" href="#" title="Journals Menu" class="header__mobile-trigger"><i class="icon-dehaze"></i><i class="icon-close"></i></a><div class="header__logos">



        
        <a href="/journal/iai" title="Infection and Immunity logo"><img id="" alt="Infection and Immunity logo" src="/pb-assets/images/pub-nav/IAI-logo-1601672963217.png"/></a>
</div><div class="hidden-sm hidden-xs hidden-md">



        
        <a href="#afterNav-c6n" class="sr-only-focusable">Skip main navigation</a><nav class="main-nav"><ul id="menubar" role="menubar" class="menubar rlist--inline"><li role="menuitem" aria-label="JOURNAL HOME" id="menu-item-pub_nav-0" class="menu-item is--current"><a href="/journal/iai"><span>JOURNAL HOME</span></a></li><li role="menuitem" aria-haspopup="true" aria-label="ARTICLES" id="menu-item-pub_nav-1" class="dropdown menu-parent is--current"><a href="#" id="pub_nav-1" data-toggle="dropdown" class="dropdown__toggle"><span>ARTICLES</span><i aria-hidden="true" class="icon-triangle-bottom"></i></a><ul aria-labelledby="pub_nav-1" role="menu" class="rlist dropdown__menu"><li role="menuitem" tabindex="-1" aria-label="CURRENT ISSUE" class="menu-item is--current"><a href="/toc/iai/current"><span>CURRENT ISSUE</span></a></li><li role="menuitem" tabindex="-1" aria-label="ACCEPTED MANUSCRIPTS" class="menu-item is--current"><a href="/toc/iai/0/ja"><span>ACCEPTED MANUSCRIPTS</span></a></li><li role="menuitem" tabindex="-1" class="menu-item"></li><li role="menuitem" tabindex="-1" aria-label="COLLECTIONS" class="menu-item is--current"><a href="/journal/iai/collections"><span>COLLECTIONS</span></a></li><li role="menuitem" tabindex="-1" aria-label="ARCHIVE" class="menu-item is--current"><a href="/loi/iai"><span>ARCHIVE</span></a></li></ul></li><li role="menuitem" id="menu-item-pub_nav-2" class="menu-item">



        
        <li role="menuitem" aria-haspopup="true" aria-label="FOR AUTHORS" id="menu-item-pub_nav-custom" class="dropdown menu-parent is--current">
	<a href="#" id="pub_nav-custom" data-toggle="dropdown" class="dropdown__toggle"><span>FOR AUTHORS</span></a>
	<ul aria-labelledby="pub_nav-custom" role="menu" class="rlist dropdown__menu">
		<li role="menuitem" tabindex="-1" aria-label="SUBMITTING" class="menu-item is--current">
			<a href="/submitting?journal=iai"><span>SUBMITTING</span></a>
		</li>
		<li role="menuitem" tabindex="-1" aria-label="WRITING YOUR PAPER" class="menu-item is--current">
			<a href="/writing-your-paper?journal=iai"><span>WRITING YOUR PAPER</span></a>
		</li>
		<li role="menuitem" tabindex="-1" aria-label="TRANSFERRING" class="menu-item is--current">
			<a href="/transferring?journal=iai"><span>TRANSFERRING</span></a>
		</li>
		<li role="menuitem" tabindex="-1" aria-label="ACCEPTED PAPERS" class="menu-item is--current">
			<a href="/accepted-papers?journal=iai"><span>ACCEPTED PAPERS</span></a>
		</li>
		<li role="menuitem" tabindex="-1" aria-label="EDITORIAL POLICIES" class="menu-item is--current">
			<a href="/editorial-policies?journal=iai"><span>EDITORIAL POLICIES</span></a>
		</li>
		<li role="menuitem" tabindex="-1" aria-label="PUBLISHING ETHICS" class="menu-item is--current">
			<a href="/publishing-ethics?journal=iai"><span>PUBLISHING ETHICS</span></a>
		</li>
	</ul>
</li>

</li><li role="menuitem" aria-haspopup="true" aria-label="ABOUT THE JOURNAL" id="menu-item-pub_nav-3" class="dropdown menu-parent is--current"><a href="#" id="pub_nav-2" data-toggle="dropdown" class="dropdown__toggle"><span>ABOUT THE JOURNAL</span><i aria-hidden="true" class="icon-triangle-bottom"></i></a><ul aria-labelledby="pub_nav-2" role="menu" class="rlist dropdown__menu"><li role="menuitem" tabindex="-1" aria-label="ABOUT IAI" class="menu-item is--current"><a href="/journal/iai/about"><span>ABOUT IAI</span></a></li><li role="menuitem" tabindex="-1" aria-label="SUBMIT" class="menu-item is--current"><a href="/journal/iai/submit"><span>SUBMIT</span></a></li><li role="menuitem" tabindex="-1" class="menu-item"></li><li role="menuitem" tabindex="-1" aria-label="SCOPE" class="menu-item is--current"><a href="/journal/iai/scope"><span>SCOPE</span></a></li><li role="menuitem" tabindex="-1" aria-label="EDITORIAL BOARD" class="menu-item is--current"><a href="/journal/iai/board-editors"><span>EDITORIAL BOARD</span></a></li><li role="menuitem" tabindex="-1" aria-label="ARTICLE TYPES" class="menu-item is--current"><a href="/journal/iai/article-types"><span>ARTICLE TYPES</span></a></li><li role="menuitem" tabindex="-1" aria-label="SUBMISSION AND REVIEW PROCESS" class="menu-item is--current"><a href="/journal/iai/submission-review-process"><span>SUBMISSION AND REVIEW PROCESS</span></a></li><li role="menuitem" tabindex="-1" aria-label="EBM SUBMISSIONS" class="menu-item is--current"><a href="/journal/iai/ebm-submission"><span>EBM SUBMISSIONS</span></a></li><li role="menuitem" tabindex="-1" aria-label="FOR REVIEWERS" class="menu-item is--current"><a href="/reviewers"><span>FOR REVIEWERS</span></a></li><li role="menuitem" tabindex="-1" aria-label="FAQ" class="menu-item is--current"><a href="/journal/iai/faq"><span>FAQ</span></a></li><li role="menuitem" tabindex="-1" aria-label="CONTACT US" class="menu-item is--current"><a href="/journal/iai/contact-us"><span>CONTACT US</span></a></li></ul></li><li role="menuitem" aria-haspopup="true" aria-label="SUBSCRIBE" id="menu-item-pub_nav-4" class="dropdown menu-parent is--current"><a href="#" id="pub_nav-3" data-toggle="dropdown" class="dropdown__toggle"><span>SUBSCRIBE</span><i aria-hidden="true" class="icon-triangle-bottom"></i></a><ul aria-labelledby="pub_nav-3" role="menu" class="rlist dropdown__menu"><li role="menuitem" tabindex="-1" aria-label="MEMBERS" class="menu-item is--current"><a href="/members"><span>MEMBERS</span></a></li><li role="menuitem" tabindex="-1" aria-label="INSTITUTIONS" class="menu-item is--current"><a href="/institutions"><span>INSTITUTIONS</span></a></li><li role="menuitem" tabindex="-1" class="menu-item"></li><li role="menuitem" tabindex="-1" aria-label="ALERTS" class="menu-item is--current"><a href="/action/showPreferences?menuTab=Alerts"><span>ALERTS</span></a></li><li role="menuitem" tabindex="-1" aria-label="RSS" class="menu-item is--current"><a href="/asm-journals-rss-feeds"><span>RSS</span></a></li></ul></li></ul><span id="afterNav-c6n" tabindex="-1"></span></nav>
</div><a href="#" data-show-target-id="search-overlay" class="hidden-lg search-trigger"><i title="Open Search Panel" class="icon-search"></i></a></div></header>




        
        <main class="content article-page">



        
        <div>









        <div data-widget-def="ux3-layout-widget" data-widget-id="62435c6d-56e5-45d8-8726-1c5a8298a1a6" class="article-container">
        



        
        <div class="mb-3">



        
        <ol aria-label="Breadcrumb" role="navigation" vocab="https://schema.org/" typeof="BreadcrumbList" class="breadcrumbs rlist--inline"><li property="itemListElement" typeof="ListItem"><a property="item" typeof="WebPage" href="https://journals.asm.org/"><span property="name">ASM Journals</span></a><meta property="position" content="1"/></li><li property="itemListElement" typeof="ListItem"><a property="item" typeof="WebPage" href="/journal/iai"><span property="name">Infection and Immunity</span></a><meta property="position" content="2"/></li><li property="itemListElement" typeof="ListItem"><a property="item" typeof="WebPage" href="/toc/iai/80/8"><span property="name">Vol. 80, No. 8</span></a><meta property="position" content="3"/></li><li property="itemListElement" typeof="ListItem"><a property="item" typeof="WebPage" href="/doi/10.1128/IAI.00206-12" aria-current="page" class="breadcrumbs__current"><span property="name">Fine Specificity of <named-content content-type='genus-species' xlink:type='simple'>Plasmodium vivax</named-content> Duffy Binding Protein Binding Engagement of the Duffy Antigen on Human Erythrocytes</span></a><meta property="position" content="4"/></li></ol>










        <div data-widget-def="general-html-asset" data-widget-id="b28fb475-91bf-4257-b86f-8120484c7481" class="container--center-content">
        



        
        <!-- /13678947/asm_leader-mob -->
<div class="leaderboard-wrapper">
<span class="leaderboard-label">Advertisement</span>
<div id='div-gpt-ad-1594664599282-0'>
  <script>
    googletag.cmd.push(function() { googletag.display('div-gpt-ad-1594664599282-0'); });
  </script>
</div>
</div>

        </div>
    
</div>

        </div>
    




        
        <link rel="stylesheet" type="text/css" href="/specs/products/asmj/releasedAssets/css/build-article.css"/><article xmlns="http://www.w3.org/1999/xhtml" data-design="pill" data-type="research-article" vocab="http://schema.org/" typeof="ScholarlyArticle"><section id="frontmatter" data-extent="frontmatter"><header><div class="core-container"><div data-article-access="free" data-article-access-type="limited" class="meta-panel"><div class="meta-panel__left-content"><div class="meta-panel__type">Research Article</div><div class="meta-panel__publication-data">18 July 2012</div></div><div class="meta-panel__right-content"><div class="meta-panel__share">



        
        <!-- Go to www.addthis.com/dashboard to customize your tools --><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share__block share__inline-links"><span class="sr-only">Share on</span><ul class="rlist--inline addthis addthis_toolbox addthis_default_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper  icon-facebook"></i></a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i></a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper  icon-linkedin"></i></a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper  icon-mail"></i></a></li></ul></div>
</div></div></div><h1 property="name">Fine Specificity of <span class="named-content" data-type="genus-species">Plasmodium vivax</span> Duffy Binding Protein Binding Engagement of the Duffy Antigen on Human Erythrocytes</h1><div class="core-relations my-3"></div><div class="contributors"><span class="authors"><span class="heading">Authors</span>: <span role="list"><span property="author" typeof="Person" role="listitem"><a href="#con1"><span property="givenName">Asim A.</span> <span property="familyName">Siddiqui</span></a></span>, <span property="author" typeof="Person" role="listitem"><a href="#con2"><span property="givenName">Jia</span> <span property="familyName">Xainli</span></a></span>, <span property="author" typeof="Person" role="listitem"><a href="#con3"><span property="givenName">Jesse</span> <span property="familyName">Schloegel</span></a></span>, <span property="author" typeof="Person" role="listitem"><a href="#con4"><span property="givenName">Lenore</span> <span property="familyName">Carias</span></a></span>, <span property="author" typeof="Person" role="listitem"><a href="#con5"><span property="givenName">Francis</span> <span property="familyName">Ntumngia</span></a></span>, <span property="author" typeof="Person" role="listitem"><a href="#con6"><span property="givenName">Menachem</span> <span property="familyName">Shoham</span></a></span>, <span property="author" typeof="Person" role="listitem"><a href="#con7"><span property="givenName">Joanne L.</span> <span property="familyName">Casey</span></a></span>, <span property="author" typeof="Person" role="listitem"><a href="#con8"><span property="givenName">Michael</span> <span property="familyName">Foley</span></a></span>, <span property="author" typeof="Person" role="listitem"><a href="#con9"><span property="givenName">John H.</span> <span property="familyName">Adams</span></a></span>, <span property="author" typeof="Person" role="listitem"><a href="#con10"><span property="givenName">Christopher L.</span> <span property="familyName">King</span></a></span></span></span></div><div class="self-citation"><span class="heading">DOI</span>: <a href="https://doi.org/10.1128/IAI.00206-12" property="sameAs">https://doi.org/10.1128/IAI.00206-12</a><span>&nbsp;&#8226;&nbsp;</span><span class="crossmark"><a data-target="crossmark" href="#" data-doi="10.1128/IAI.00206-12" class="crossmark__link"><img alt="Check for updates on crossmark" src="/specs/products/asmj/releasedAssets/images/cross-mark.png" class="crossmark__logo"/></a></span></div><div class="info-panel"><div class="info-panel__metrics info-panel__item">



        
        







        <div class="toolbar-metric-container">
            <input class="toolbar-metric__data" type="hidden" name="json" value='{"data":{"menuSections":[{"total":"200","id":"downloads","title":"downloads"},{"total":"12","id":"citations","title":"citations"}],"doi":"10.1128/IAI.00206-12"},"thisWidget":{"properties":{"identifier":"","headingLvl":"h2","wrapperClass":"","citationMetricId":"2","downloadMetricId":"1","headingClass":"","ux3/template":"","wrapperTag":"div","title":"","linkToFullPage":""}}}'>
        </div>
    

</div><div class="info-panel__favorite info-panel__item">



        
        <div class="article-tools"><a href="/action/addCitationAlert?doi=10.1128%2FIAI.00206-12" target="_blank" title="Track Citations" class="article-tools__citation btn btn--slim btn-secondary btn--inverse btn--transparent"><i class="icon-alert-bell"></i></a></div>
</div><div class="info-panel__alerts info-panel__item"></div><div class="info-panel__citations info-panel__item"><a href="#tab-citations" title="View Citations" class="btn btn--slim btn--inverse"><i aria-hidden="true" class="icon-format_quote"></i></a></div><div class="info-panel__formats info-panel__item"><a href="https://journals.asm.org/doi/full/10.1128/IAI.00206-12" class="btn btn--slim btn--inverse"><span>Full Text</span></a><a href="/doi/reader/10.1128/IAI.00206-12" class="btn btn--slim btn--pdf"><span>PDF/EPUB</span></a></div></div></div></header><nav data-core-nav="article"><header><div class="core-self-citation">



        
        <a href="/journal/iai" class="sections-navbar__title">IAI</a>
<div class="core-enumeration"><span property="isPartOf" typeof="PublicationVolume">Volume <span property="volumeNumber">80</span></span><span class="delimiter">, </span><span property="isPartOf" typeof="PublicationIssue">Number <span property="issueNumber">8</span></span><br /><span property="datePublished">August 2012</span></div></div><nav></nav></header><ul xmlns="http://www.w3.org/1999/xhtml"><li><a href="#abstract">ABSTRACT</a></li><li><a href="#sec-1">INTRODUCTION</a></li><li><a href="#sec-2">MATERIALS AND METHODS</a></li><li><a href="#sec-3">RESULTS</a></li><li><a href="#sec-4">DISCUSSION</a></li><li><a href="#acknowledgments">ACKNOWLEDGMENTS</a></li><li><a href="#bibliography">REFERENCES</a></li></ul><footer></footer></nav><div id="abstracts"><div class="core-container"><section id="abstract" property="abstract" typeof="Text" role="doc-abstract"><h2 property="name">ABSTRACT</h2><div role="paragraph"><span class="named-content" data-type="genus-species">Plasmodium vivax</span> invasion of human erythrocytes requires interaction of the <span class="named-content" data-type="genus-species">P. vivax</span> Duffy binding protein (PvDBP) with its host receptor, the Duffy antigen (Fy) on the erythrocyte surface. Consequently, PvDBP is a leading vaccine candidate. The binding domain of PvDBP lies in a cysteine-rich portion of the molecule called region II (PvDBPII). PvDBPII contains three distinct subdomains based upon intramolecular disulfide bonding patterns. Subdomain 2 (SD2) is highly polymorphic and is thought to contain many key residues for binding to Fy, while SD1 and SD3 are comparatively conserved and their role in Fy binding is not well understood. To examine the relative contributions of the different subdomains to binding to Fy and their abilities to elicit strain-transcending binding-inhibitory antibodies, we evaluated recombinant proteins from SD1+2, SD2, SD3, and SD3+, which includes 24 residues of SD2. All of the recombinant subdomains, except for SD2, bound variably to human erythrocytes, with constructs containing SD3 showing the best binding. Antisera raised in laboratory animals against SD3, SD3+, and SD2+3 inhibited the binding of full-length PvDBPII, which is strain transcending, whereas antisera generated to SD1+2 and SD2 failed to generate blocking antibodies. All of the murine monoclonal antibodies generated to full-length PvDBPII that had significant binding-inhibitory activity recognized only SD3. Thus, SD3 binds Fy and elicits blocking antibodies, indicating that it contains residues critical to Fy binding that could be the basis of a strain-transcending candidate vaccine against <span class="named-content" data-type="genus-species">P. vivax</span>.</div></section></div></div></section><section id="bodymatter" data-extent="bodymatter" property="articleBody" typeof="Text"><div class="core-container"><section id="sec-1" data-type="intro"><h2>INTRODUCTION</h2><div role="paragraph"><span class="named-content" data-type="genus-species">Plasmodium vivax</span> Duffy binding protein (PvDBP) is a 140-kDa protein secreted by micronemes, a parasite organelle at the apical end of the merozoite as it invades erythrocytes (<a href="#B2" role="doc-biblioref" data-xml-rid="B2">2</a>). The binding domain of PvDBP has been narrowed to a cysteine-rich region (referred to as region II or PvDBPII) of the protein (<a href="#B6" role="doc-biblioref" data-xml-rid="B6">6</a>, <a href="#B7" role="doc-biblioref" data-xml-rid="B7">7</a>) and comprises the prototypic Duffy binding-like (DBL) domain found in other erythrocyte-binding <span class="named-content" data-type="genus-species">Plasmodium</span> proteins (e.g., EBA-1, JESEBL, and BAEBL) and in cytoadherence proteins (e.g., PfEMP-1) (<a href="#B1" role="doc-biblioref" data-xml-rid="B1">1</a>). PvDBPII and the <span class="named-content" data-type="genus-species">Plasmodium knowlesi</span> DBPÎ± (PkDBPÎ±) DBL domain, an ortholog of PvDBPII with 71% sequence identity, appear to be the only known parasite DBL domain ligands that bind Fy (<a href="#B18" role="doc-biblioref" data-xml-rid="B18">18</a>, <a href="#B39" role="doc-biblioref" data-xml-rid="B39">39</a>).</div><div role="paragraph">Region II of PvDBP (PvDBPII) is 330 amino acids (aa) in length and contains 12 cysteines that are conserved among different DBL domains. PvDBPII is one of the most promising vaccine targets because binding to its cognate receptor on erythrocytes, the Duffy antigen (designated Fy), is vital for erythrocyte invasion (<a href="#B4" role="doc-biblioref" data-xml-rid="B4">4</a>, <a href="#B23" role="doc-biblioref" data-xml-rid="B23">23</a>). Individuals who fail to express Fy on their erythrocytes are generally resistant to infection with <span class="named-content" data-type="genus-species">P. vivax</span> and to the related simian malaria parasite <span class="named-content" data-type="genus-species">P. knowlesi</span>, which also infects humans (<a href="#B23" role="doc-biblioref" data-xml-rid="B23">23</a>, <a href="#B24" role="doc-biblioref" data-xml-rid="B24">24</a>). The observation that both artificially induced and naturally acquired antibodies (Abs) to PvDBPII block the invasion of erythrocytes by <span class="named-content" data-type="genus-species">P. vivax</span> (<a href="#B16" role="doc-biblioref" data-xml-rid="B16">16</a>) and correlate with protection against <span class="named-content" data-type="genus-species">P. vivax</span> infection in populations where malaria is endemic (<a href="#B22" role="doc-biblioref" data-xml-rid="B22">22</a>) supports PvDBPII as an attractive vaccine candidate.</div><div role="paragraph">The recently determined crystal structure of the <span class="named-content" data-type="genus-species">P. knowlesi</span> DBPÎ± (PkDBPÎ±) DBL domain (<a href="#B34" role="doc-biblioref" data-xml-rid="B34">34</a>) and PvDBPII (<a href="#B5" role="doc-biblioref" data-xml-rid="B5">5</a>) indicates that the 12 conserved cysteine residues form intradomain disulfide bridges that can be used to divide the DBL domain into three subdomains. Subdomain 1 (SD1), the smallest, includes cysteines 1 to 4, SD2 includes cysteines 5 and 6, and SD3, the largest, comprises cysteines 7 to 12. SD2 is highly polymorphic, whereas the other subdomains are relatively conserved (<a href="#B40" role="doc-biblioref" data-xml-rid="B40">40</a>), suggesting that SD2 is a target of immune selection. Alanine mutagenesis of selected residues in PvDBPII demonstrated critical binding residues in SD2, although mutagenesis of residues outside the SD2 area can also impair binding to Fy (<a href="#B17" role="doc-biblioref" data-xml-rid="B17">17</a>, <a href="#B37" role="doc-biblioref" data-xml-rid="B37">37</a>). It has recently been proposed that PvDBPII forms a dimer that is driven by engagement with its receptor and SD2 contains the critical binding residues (<a href="#B5" role="doc-biblioref" data-xml-rid="B5">5</a>). In the study upon which this model is based, PvDBPII was cocrystallized with sodium selenate in the absence of its natural ligand, the N-terminal binding domain of Fy. Thus, this crystal structure may not represent the conformation of PvDBPII when it is complexed with the N-terminal domain of Fy. In contrast, cocrystallization of the DBL3x domain of <span class="named-content" data-type="genus-species">P. falciparum</span> erythrocyte membrane protein 1, which bears close structural homology to PvDBPII, with its natural ligand chondroitin A sulfate (CSA), showed that SD3 contained the minimal binding region (<a href="#B31" role="doc-biblioref" data-xml-rid="B31">31</a>, <a href="#B32" role="doc-biblioref" data-xml-rid="B32">32</a>). Since the actual binding mechanism of PvDBPII remains unknown, it would not be surprising if the interaction with the receptor involved more than one interaction or if this interaction required conformational induction for recognition of a secondary receptor.</div><div role="paragraph">Here we postulate that SD3 is essential for PvDBPII binding to Fy and, because it is comparatively conserved, could form the basis of a strain-transcending blood stage vaccine. We cloned and expressed subdomains of PvDBPII and demonstrated that SD3 binds to Fy and can elicit strain-transcending binding-inhibitory Abs (BIAbs) to full-length PvDBPII. Moreover, we show that binding-inhibitory monoclonal Abs (MAbs) to PvDBPII target residues in SD3, supporting the critical role of SD3 in binding to Fy.</div></section><section id="sec-2" data-type="materials methods"><h2>MATERIALS AND METHODS</h2><section id="sec-2-1"><h3>Blood samples.</h3><div role="paragraph">Erythrocytes from finger stick or peripheral venous blood was obtained from healthy normal volunteers after informed consent was obtained. The ethical review boards of the University Hospitals of Cleveland approved the protocol for blood drawing.</div></section><section id="sec-2-2"><h3>Expression of DBPII subdomains.</h3><div role="paragraph">Expression of full-length PvDBPII of strain Salvador, SalI, and other major variants of PvDBPII referred to as AH, O, and P (their sequences in relationship to SalI are shown in supplemental Table 1 of reference <a href="#B22" role="doc-biblioref" data-xml-rid="B22">22</a>) was performed as previously described (<a href="#B16" role="doc-biblioref" data-xml-rid="B16">16</a>). The AH, O, and P variants represent haplotypes that account for 57% of the <span class="named-content" data-type="genus-species">P. vivax</span> infections isolated from Papua New Guinean children (<a href="#B12" role="doc-biblioref" data-xml-rid="B12">12</a>), and polymorphic residues (<i>n</i> = 14) occurred in &gt;1% of over 100 PvDBPII sequences worldwide. Expression of SD1+2, SD2, SD3, SD3+, and SD2+3 of PvDBPII was performed in the Gateway expression system (Invitrogen, Carlsbad, CA) by following the manufacturer's instructions. The sequences corresponding to SD1+2, SD2, SD3, SD3+, and SD2+3 were amplified by using a PvDBPII (SalI) recombinant plasmid (<a href="#B11" role="doc-biblioref" data-xml-rid="B11">11</a>, <a href="#B33" role="doc-biblioref" data-xml-rid="B33">33</a>) as the template with primers SD1+2F and SD2R, primers SD2F and SD2R, primers SD3F and SD3R, primers SD3+F and SD3+R, and primers SD2F and SD3R, respectively. The forward and reverse primers used for different SD constructs are as follows: SD2F, CACCATGAAGGAACTTACGAATTTGGTAAATAATACAGAC; SD2R, CTAGTGATGGTGAT GGTGATGTATATTTACCGCAAC; SD3F, CACCATGCCGCAGATATATAGATGGATTCGAGAA; SD3R, CTAGTGATGGTGATGGTGATGCTCTTCAACGGAACA; SD3+F, CACCATGTACTCAGTTAAAAAAAGATTAAAG; SD3+R, CTAGTGATGGTGATGGTGATGTGTCACAACTTCCTGAGT; SD2+3F, CACCATGAAAAACTGTAATTATAAGAGAAAACGTCGG; SD2+3R, same as SD3R.</div><div role="paragraph">The first four extra bases in the forward primers were added to facilitate the directional TOPO cloning in the pENTR vector, and in the reverse primer, additional bases were included to create a C-terminal 6ÃHis tag for affinity purification of the recombinant protein on Ni-nitrilotriacetic acid agarose. The expression of the recombinant proteins was done in the pDEST42 expression vector, followed by their induction in codon-optimized <span class="named-content" data-type="genus-species">Escherichia coli</span> BL21(DE3) CodonPlus RIL host cells.</div></section><section id="sec-2-3"><h3>Refolding and purification.</h3><div role="paragraph">Refolding and purification of <span class="named-content" data-type="genus-species">P. vivax</span> DBPII subdomains followed a modified method previously described (<a href="#B33" role="doc-biblioref" data-xml-rid="B33">33</a>). Briefly, the cell pellet from 1 liter of culture was resuspended in 40 ml of lysis buffer (20 mM Tris-HCl, pH 7.5, 10 mM EDTA, 1% Triton X-100). The sample was lysed by two alternate cycles of freezing at â70Â°C and thawing in cold water, followed by six cycles of sonication on ice. The lysate was centrifuged at 10,000 Ã <i>g</i> for 30 min at 4Â°C. The supernatant was removed, and the pellet containing inclusion bodies was solubilized in a buffer consisting of 50 mM 3-(cyclohexylamino)-1-propane sulfonic acid (CAPS) (pH 11.0), 0.6% <i>N</i>-lauroylsarcosine, and 0.1 mM dithiothreitol (DTT) at a final concentration of 10 to 20 mg/ml and incubated on a shaking platform for 15 to 20 min at room temperature (RT). The product was again centrifuged as stated above to clarify the supernatant. This solubilized preparation was then diluted 1:1 with urea buffer (8 M urea, 100 mM NaH<sub>2</sub>PO<sub>4</sub>, 10 mM Tris-Cl [pH 8.0]) and partially purified on a 1-ml HisTrap HP column. The bound protein was eluted with urea buffer containing 250 mM imidazole.</div><div role="paragraph">For refolding, the eluted protein was rapidly diluted 1:100 with refolding buffer (50 mM sodium phosphate, pH 7.2, 1 mM reduced glutathione, 0.1 mM oxidized glutathione, 1 M urea, 0.5 M arginine) at RT and stirred for at least 36 h at 4Â°C prior to dialysis against 50 mM sodium phosphate, pH 6.5, containing 1 M urea, with three changes. Passing of the resulting protein preparation over a 1-ml HiTrap FF cation-exchange chromatography column further purified the protein. The eluted product was then desalted and concentrated with an Amicon Ultra-4 column with a 10,000 molecular weight cutoff (MWCO; Millipore Inc.). Refolded proteins under reducing and nonreducing conditions (with and without DTT) migrated at different sizes on SDS-PAGE, suggesting that all of the refolded proteins acquired a tertiary shape.</div></section><section id="sec-2-4"><h3>Immunization of rats with DBP subdomains.</h3><div role="paragraph">The recombinant and purified subdomains were used to immunize rats in duplicate with 50 Î¼g of antigen emulsified with an equal volume of the adjuvant TiterMax gold (Sigma-Aldrich) in a 100-Î¼l final volume. All injections were subcutaneous. Two boosters of the same dose were administered at a 2-week interval, and final blood samples were collected a week following the administration of the final booster.</div></section><section id="sec-2-5"><h3>Antibody purification.</h3><div role="paragraph">One milliliter of rat antiserum raised against recombinant PvDBPII, SD1+2, SD2, SD3, SD3+, or SD2+3 was affinity purified by passage over a column prepared by coupling 5 mg of PvDBPII (SalI) to cyanogen bromide-activated Sepharose 4B (GE Healthcare). After the column was washed three times with 50 mM Tris-HCl, pH 7.5, containing 0.5 M NaCl, the bound antibody was eluted with 0.1 M glycine, pH 2.4. One-milliliter fractions were collected in tubes containing 30 Î¼l of 3 M Tris-HCl at pH 8.8 and 20 Î¼l of 5 M NaCl to neutralize the eluate. The fractions containing Abs, as measured by optical density at 280 nm, were pooled and concentrated by Amicon Ultra-15 with a 30,000 MWCO and stored at â20Â°C.</div></section><section id="sec-2-6"><h3>Assays of PvDBPII binding to erythrocytes.</h3><div role="paragraph">PvDBPII binding to red blood cells (RBCs) was assessed using a flow cytometry-based assay (<a href="#B16" role="doc-biblioref" data-xml-rid="B16">16</a>, <a href="#B35" role="doc-biblioref" data-xml-rid="B35">35</a>) and a conventional erythrocyte-binding assay where antigen binding was determined by a Western blotting approach (<a href="#B33" role="doc-biblioref" data-xml-rid="B33">33</a>). For the flow cytometry assay, finger prick blood was collected (â¼100 Î¼l) directly into 0.5 ml of phosphate-buffered saline (PBS) and washed twice in PBS using a microcentrifuge at 10,000 rpm for 1 min. Following the final wash, 10 Î¼l of packed RBCs was resuspended in 40 Î¼l of PBS (1:5 dilution). One microliter of the 1:5-diluted RBCs was further diluted into 100 Î¼l PBSâ1% bovine serum albumin (BSA) to yield a total of â¼10<sup>6</sup> erythrocytes. Recombinant PvDBPII (0.2 Î¼g total) was added to the 100-Î¼l erythrocyte suspension, which was incubated for 2 h at RT or overnight at 4Â°C. Production of recombinant PvDBPII and the different variants was performed as described previously (<a href="#B16" role="doc-biblioref" data-xml-rid="B16">16</a>). Following binding to PvDBPII, each sample was washed three times with PBSâ1% BSA and incubated (1 h in the dark at 4Â°C) with rabbit anti-PvDBPII (1:8,000; a concentration that had no inhibitory effect on PvDBPII binding to erythrocytes [personal observation]), washed, and then incubated with a phycoerythrin-conjugated goat anti-rabbit secondary antibody (Invitrogen, Carlsbad, CA). The amount of antibody was titrated to obtain the optimal signal with each lot of antibody (dilutions ranging from 1:5 to 1:50). LSRII-based (Becton Dickinson, Franklin Lakes, NJ) flow cytometry evaluated 50,000 erythrocytes (using a 488-nm laser). Relative binding was determined by multiplying the mean fluorescence index by the percentage of erythrocytes bound. Binding inhibition was performed by adding polyclonal Abs or MAbs at the specified concentrations for 30 min at 37Â°C with recombinant PvDBPII prior to the addition of RBCs. For most monoclonal and polyclonal sera, blocking of binding occurred almost immediately when they were added to erythrocytes; however, a few MAbs showed slower blocking kinetics (e.g., MAbs 2D10 and 2H2 required 15 to 30 min of preincubation to achieve maximal blocking activity [data not shown]). Therefore, all of the Abs were preincubated with PvDBPII for 30 min prior to addition to RBCs.</div><div role="paragraph">For the conventional erythrocyte-binding assay, 1 ml heparinized peripheral venous blood was washed three times with RPMI medium at RT by centrifugation for 5 min at 1,200 rpm and 33% hematocrit was prepared by adding 1 ml of RPMI medium to 0.5 ml of packed RBC pellet. Duffy-negative individuals were used as controls. To measure subdomain binding, 10 Î¼g of purified protein in a final volume of 400 Î¼l of RPMI medium containing 60 Î¼l of fetal bovine serum was incubated at RT for 15 min, and then both of the suspensions (Duffy positive and Duffy negative) were added separately and the mixtures were incubated at RT on a rocking platform for 1 h to allow binding. After incubation, the suspensions were layered on 600 Î¼l of dibutyl phthalate (Sigma-Aldrich, St. Louis, MO) and centrifuged at 13,000 rpm for 1 min. The supernatant was carefully aspirated and discarded (or saved for protein analysis), keeping the RBC pellet intact and making sure that there was no residual unbound protein or oil droplets left. Twenty microliters of 1.5 M NaCl was added to 100 Î¼l of packed RBCs to elute the bound protein. Tubes were kept at RT for 1 min and centrifuged at 13,000 rpm for 1 min to collect the supernatant containing the eluted protein (â¼40 Î¼l). The supernatants were subjected to 12% SDS-PAGE and analyzed by Western blotting using the anti-PvDBPII or anti-His MAb.</div></section><section id="sec-2-7"><h3>Phagemid expression system.</h3><div role="paragraph">Preparation of phagemids was adapted from previously described protocols for the expression of other malarial antigens (<a href="#B14" role="doc-biblioref" data-xml-rid="B14">14</a>). Briefly, the portions of the genes encoding the five PvDBPII subdomain constructs (SD1, SD1+2, SD1+2+3, SD2+3, and SD3) were cloned into the phagemid pHEN-H6 via PstI and NotI for display on the surface of an M13 bacteriophage. After purification, the ligation products were used to transform electrocompetent <span class="named-content" data-type="genus-species">E. coli</span> TG1 and then cultured overnight on 2Ã yeast extract-tryptone (YT) agar containing 50 Î¼g ml<sup>â1</sup> ampicillin. The resulting colonies were screened by PCR for the presence of an insert of the correct size. These PCR products were sequenced to confirm correct sequence integrity, orientation, and frame. TG1 clones containing the pHENH6/DBPII subdomains were grown to an optical density of 2.0 in 10 ml of 2Ã YT broth with 50 mg ml<sup>â1</sup> ampicillin. M13K07 helper phage (1 Ã 10<sup>12</sup> PFU) was added and allowed to infect the cells, and then 10 ml of the culture was added to 200 ml of broth containing 70 Î¼g ml<sup>â1</sup> kanamycin and 50 Î¼g ml<sup>â1</sup> ampicillin and incubated at 37Â°C for 16 h with shaking to allow phage production. The constructs were each expressed as chimeras, fused with the pIII minor coat protein of the phage. As with other coat proteins, pIII is translocated to, folded, and packaged in the gel-like, oxidizing environment of the bacterial periplasm. Following packaging, the nonlytic phage particles are secreted from the bacteria into the culture supernatant. The phage particles were purified by centrifugation at 8,000 Ã <i>g</i> for 15 min to pellet the bacteria, and 50 ml 5Ã polyethylene glycol-NaCl solution was added to the supernatant containing the phage. The phage-polyethylene glycol was incubated on ice for 4 h to allow the phage to precipitate. Following phage precipitation, the preparation was centrifuged at 8,000 Ã <i>g</i> for 15 min in order to pellet the phage. The supernatant was discarded, and the phage was resuspended in 1 ml PBS and stored at â70Â°C. Phage clones were normalized for insert concentrations using the c-Myc epitope tag immediately downstream from the NotI site in the pHENH6 vector. An enzyme-linked immunosorbent assay (ELISA) was performed using MAb 9E10 (anti-Myc) on serial dilutions of individual phage preparations displaying the various PvDBPII subdomains to be analyzed. The phage preparations were then diluted such that they all produced similar titration curves when the ELISA was repeated with those dilutions. At that point, the preparations all possessed similar levels of Myc epitope tag and therefore equivalent levels of the respective PvDBPII subdomains.</div></section><section id="sec-2-8"><h3>Computer modeling of PvDBPII.</h3><div role="paragraph">The protein models were created by homology model building based upon the crystal structure of <span class="named-content" data-type="genus-species">P. knowlesi</span> (Protein Data Bank [PDB] code <a href="file:">2C6J</a>) (<a href="#B34" role="doc-biblioref" data-xml-rid="B34">34</a>) by using SWISSMODEL, refined with CNS, and displayed with program O (<a href="#B20" role="doc-biblioref" data-xml-rid="B20">20</a>). The programs MOLSCRIPT and Raster3D were used to display the models in ribbon diagrams with selected side chains in ball-and-stick representations.</div></section></section><section id="sec-3" data-type="results"><h2>RESULTS</h2><section id="sec-3-1"><h3>PvDBPII subdomain structure.</h3><div role="paragraph">PvDBPII is a cysteine-rich region that lies in the DBP extracellular domain and is responsible for the binding of Fy on host erythrocytes (<a href="#F1">Fig. 1A</a>). A homology-built model of PvDBPII (<a href="#F1">Fig. 1B</a>) based on a recent crystal structure of the <span class="named-content" data-type="genus-species">P. knowlesi</span> DBPÎ± domain with 71% sequence identity to PvDBPII (<a href="#B34" role="doc-biblioref" data-xml-rid="B34">34</a>). There are 12 conserved cysteine residues that are all predicted to be involved in intradomain disulfide bridges that can be used to divide the DBL domain into three subdomains. SD1, SD2, and SD3 have two, one, and three disulfide bonds, respectively, and are composed of 12 alpha helices. The three disulfide bridges in SD3 appear to stabilize the two long helical âtowers.â Also shown are the 14 common polymorphic amino acid residues (<a href="#B13" role="doc-biblioref" data-xml-rid="B13">13</a>), 12 of which are expressed on the surface of the molecule. Notable is the polymorphic residue at position 437, which is only partially surface exposed near the junction of SD2 and SD3. None of the polymorphic residues examined occur within SD1, 11 occur in SD2, and 3 occur in SD3.</div><div class="figure-wrap"><header><div class="label">Fig 1</div></header><figure id="F1" class="graphic"><img src="/cms/10.1128/IAI.00206-12/asset/c69d37b7-4fcc-43ed-bf89-0cd583536259/assets/graphic/zii9990997380001.jpeg" /><figcaption><span class="heading">Fig 1</span> The DBL ligand domain (region II) is the part of the DBP extracellular domain that binds to the erythrocyte receptor. Region II is divided into three subdomains (A). SD1 is composed of residues Asn257 to Leu299 and has two intrasubdomain disulfides, Cys263-Cys292 and Cys276-Cys283. SD2 is composed of residues Tyr317 to Glu432 and has one intrasubdomain disulfide, Cys346-Cys423. SD3 is composed of residues Pro433 to Ser554 and has three intrasubdomain disulfides, Cys461-Cys478, Cys473-Cys553, and Cys482-Cys551. (B) Homology-built models of PvDBPII based on the PkDBPÎ± crystal structure (PDB code <a href="file:">2C6J</a>) (<a href="#B12" role="doc-biblioref" data-xml-rid="B12">12</a>). The model designated PvDBPII shows 11 of the 14 polymorphic residues (residues 385, 386, and 417 are hidden in this view). N and C are the two termini of the molecule. Also indicated are subdomains. Disulfide bridges are indicated by thick black bonds between yellow spheres (sulfur atoms). Of note, the amino acid numbering system used for PvDBPII is based on our previous studies and differs from that of the published PvDBPII crystal structure (<a href="#B5" role="doc-biblioref" data-xml-rid="B5">5</a>). Subtraction of 46 from the amino acid residue numbering in the present report will produce numbering that corresponds to that of Batchelor et al. (<a href="#B5" role="doc-biblioref" data-xml-rid="B5">5</a>).</figcaption></figure></div></section><section id="sec-3-2"><h3>Functional analysis of PvDBPII subdomains.</h3><div role="paragraph">Previous studies of PkDBPII have suggested that the entire DBL domain may not be required for receptor recognition, but PvDBPII may be different (<a href="#B28" role="doc-biblioref" data-xml-rid="B28">28</a>). To examine the functional roles of each PvDBPII subdomain and their combinations in binding to their receptor, we generated several recombinant molecules corresponding to the different subdomains. These molecules were cloned from the parent plasmid PvDBPII (SalI), expressed, purified, and refolded to a homogeneity identical to that of full-length PvDBPII. All of the proteins migrated to their approximate molecular sizes, including their poly-HIS tags and linkers (PvDBPII, â¼42 kDa; SD2+3, â¼32 kDa; SD2, â¼14 kDa; SD3, â¼18 kDa; SD3+, â¼20 kDa; SD1+2, â¼22 kDa), on SDS-PAGE (<a href="#F2">Fig. 2A</a>) and were recognized by rabbit polyclonal sera generated to full-length PvDBPII (<a href="#F2">Fig. 2B</a>).</div><div class="figure-wrap"><header><div class="label">Fig 2</div></header><figure id="F2" class="graphic"><img src="/cms/10.1128/IAI.00206-12/asset/4d373bce-bc85-42f8-8fcb-64d17c3cf1a3/assets/graphic/zii9990997380002.jpeg" /><figcaption><span class="heading">Fig 2</span> (A) Coomassie-stained purified recombinant PvDBPII and the different subdomain constructs. (B) Western blot assay of different fragments recognized by the polyclonal rabbit anti-PvDBPII Abs in the order of loading. The molecular masses of markers (in lanes Mr) are indicated on the left.</figcaption></figure></div></section><section id="sec-3-3"><h3>PvDBPII subdomains show differential binding to RBCs.</h3><div role="paragraph">The ability of PvDBPII subdomains to bind the Fy antigen on the surface of erythrocytes was assessed by flow cytometry (<a href="#F3">Fig. 3A</a>) and the conventional erythrocyte-binding assay (<a href="#F3">Fig. 3B</a>). We have recently shown that PvDBPII binds Duffy-positive erythrocytes expressing the Fy<sup>b</sup> phenotype (a single amino acid substitution that is the major Fy polymorphism within the PvDBPII binding motif) better than Fy<sup>a</sup> (<a href="#B21" role="doc-biblioref" data-xml-rid="B21">21</a>). Therefore, all of the binding experiments were performed with erythrocytes expressing Fy<sup>b</sup>. All constructs failed to bind Duffy-negative cells (<a href="#F3">Fig. 3A</a>, open circles). We observed a consistent pattern in which constructs containing SD3 bound better than constructs with only SD2, although none of the constructs bound as well as full-length PvDBPII. Most surprisingly, SD3+, which contains SD3 plus 24 aa of SD2, bound Fy<sup>+</sup> erythrocytes better than did SD2+3, which contains all of SD2. At least in the recombinant constructs, SD3+ may present a more accessible, conformationally correct structure for erythrocyte binding than recombinant SD2+3.</div><div class="figure-wrap"><header><div class="label">Fig 3</div></header><figure id="F3" class="graphic"><img src="/cms/10.1128/IAI.00206-12/asset/12ec6d94-b6f1-4357-acb3-e0ecab89d2f0/assets/graphic/zii9990997380003.jpeg" /><figcaption><span class="heading">Fig 3</span> Binding of the different subdomain constructs to human erythrocytes that are Duffy positive (solid circles) and Duffy negative (open circles) (A) and binding of the same constructs to Fy-positive erythrocytes (+) and to erythrocytes treated with chymotrypsin to remove the DA antigen (â) (B). The molecular masses of markers (in lane M) are indicated on the left. Binding assays are described in Materials and Methods. MFI, mean fluorescence index.</figcaption></figure></div></section><section id="sec-3-4"><h3>Abs to SD3-containing proteins block PvDBPII-erythrocyte binding.</h3><div role="paragraph">We evaluated affinity-purified polyclonal Abs directed to PvDBPII and the various subdomains for their ability to functionally block the binding of PvDBPII to erythrocytes (<a href="#F4">Fig. 4</a>). Affinity-purified rat Abs to PvDBPII and the different constructs had similar ELISA endpoint titers (defined as the concentration of Ab which gives an optical density 2-fold higher than that of preimmune serum). The endpoint titers were 260 pg/ml for SD2+3, 260 pg/ml for full-length PvDBPII, 380 pg/ml for SD1+2, 380 pg/ml for SD3+, 420 pg/ml for SD3, and 460 pg/ml for SD2. The binding of PvDBPII (SalI variant) (<a href="#B26" role="doc-biblioref" data-xml-rid="B26">26</a>) was blocked best by Abs directed to full-length PvDBPII (<a href="#F4">Fig. 4A</a>), followed by Abs to SD3+, SD2+3, and SD3. Comparatively little blocking activity was observed with Abs raised to SD1+2 and SD2 (<a href="#F4">Fig. 4A</a>). Of note, inhibitory Abs (anti-SD3 and anti SD3+) were affinity purified against full-length PvDBPII and thus likely recognize epitopes on the surface of total PvDBPII.</div><div class="figure-wrap"><header><div class="label">Fig 4</div></header><figure id="F4" class="graphic"><img src="/cms/10.1128/IAI.00206-12/asset/d0fe490f-895c-4387-b2b3-96c1a07633dd/assets/graphic/zii9990997380004.jpeg" /><figcaption><span class="heading">Fig 4</span> Inhibition by Abs of the erythrocyte binding of various constructs of PvDBPII. (A) Abilities of affinity-purified rat polyclonal Abs generated to the SD constructs to block the binding of full-length PvDBPII (SalI variant) to Duffy<sup>+</sup> erythrocytes. (B) Ability of anti-PvDBPII Ab to block the binding of recombinant PvDBPII (SalI variant, closed circles) and AH, O, or P variants of PvDBPII (open circles). Differences between the inhibition of SalI PvDBPII and that of other variants are significant at a <i>P</i> value of &lt;0.001 (***). (C) The ability of Abs to SD3+ to inhibit the binding of full-length PvDBPII (SalI variant, closed circles) and other PvDBPII variants (open circles). Differences are not statistically significant (all <i>P</i> values are &gt;0.1, except for the P variant, for which the <i>P</i> value is 0.02 [*]). Each circle represents the mean inhibition (tested in duplicate) of a single erythrocyte donor. Inhibition of binding to the different variants was tested with erythrocytes from the same donor. Statistical testing was done with Student's <i>t</i> test. Affinity-purified Abs to the full-length construct were used at 2 Î¼g/ml, and those to the other constructs were used at 5 Î¼g/ml. These concentrations represent the optimal blocking activities for all of the sera tested by titration curves.</figcaption></figure></div><div role="paragraph">We then wanted to examine how blocking Abs generated to the different constructs inhibited binding to other common and naturally occurring PvDBPII variants. We selected three haplotypes that have been previously characterized (<a href="#B12" role="doc-biblioref" data-xml-rid="B12">12</a>, <a href="#B16" role="doc-biblioref" data-xml-rid="B16">16</a>). These PvDBPII haplotypes are common in populations in Papua New Guinea in which <span class="named-content" data-type="genus-species">P. vivax</span> infection is endemic and vary from the SalI variant (the likely basis for a vaccine) by 5 aa (O variant), 8 aa (AH variant), and 11 aa (P variant). Blocking Abs raised to full-length PvDBPII (SalI) inhibited the binding of the homologous PvDBPII variant SalI better than that of heterologous haplotypes AH, O, and P (<a href="#F4">Fig. 4B</a>). In contrast, Abs generated to SD3+ equally inhibited the binding of the AH and O variants but showed a slight reduction in inhibition for variant P (<a href="#F4">Fig. 4C</a>). Affinity-purified Abs to SD3 (SalI variant) also show blocking activity against homologous SalI PvDBPII (46% Â± 6% inhibition) similar to that against heterologous AH (39% Â± 5% inhibition), O (44% Â± 5% inhibition), and P (41% Â± 7% inhibition). Similarly, affinity-purified Abs to SD2+3 (SalI variant) demonstrated blocking activity against homologous SalI PvDBPII (63% Â± 5% inhibition) similar to that against heterologous AH (60% Â± 7% inhibition), O (58% Â± 6% inhibition), and P (52% Â± 9% inhibition). This suggests that BIAbs directed to constructs containing SD3 can be strain transcending. Of note, the blocking activity of serum raised to SD3+ that was not affinity purified was similar to that of affinity-purified Abs, with an overall trend toward higher blocking activity against both heterologous and homologous PvDBPII variants (percent inhibition: SalI, 80% Â± 7%; AH, 76% Â± 9%; O, 78% Â± 5%; P, 71% Â± 11%). Similar trends were observed with non-affinity-purified blocking Abs induced by SD3 and SD2+3 (data not shown).</div></section><section id="sec-3-5"><h3>MAbs that block the binding of PvDBPII target SD3.</h3><div role="paragraph">A panel of MAbs produced in response to two variants of DBPII was recently characterized (<a href="#B26" role="doc-biblioref" data-xml-rid="B26">26</a>). There were eight hybridoma clones from PvDBPII variant C (2A6, 3A4, 2C6, 3C9, 1D2, 2D10, 2F12, and 2H2) and one from PvDBPII-SalI (3D10) that secreted specific IgG MAbs. Secreted MAbs were purified by protein G affinity chromatography. The ELISA endpoint titers of the MAbs at 17 ng/ml to variant SalI of PvDBPII were similar, with the exception of 3D10 and 1D2, which were 2 and 167 ng/ml, respectively. Five of the nine MAbs demonstrated significant blocking of PvDBPII (SalI) binding to erythrocytes, whereas four did not (<a href="#F5">Fig. 5A</a>). To determine which regions of PvDBPII are recognized by the MAbs, we examined their reactivities to the different subdomain constructs (<a href="#F5">Fig. 5B</a>). Five of the nine MAbs tested recognized only constructs containing SD3, suggesting that they recognize epitopes contained within SD3. In contrast MAb 3D10 most strongly recognized the construct containing SD1 and MAb 1D2 primarily recognized constructs containing SD2, suggesting that these MAbs contain epitopes that include SD1 and SD2, respectively. Importantly, MAbs that block the binding of PvDBPII to erythrocytes (2C6, 3C9, 2D10, 2H2, and 2F12) recognized only products containing SD3. This demonstrates that neutralizing epitopes also occur within SD3 and that these more conserved epitopes could form the basis of a strain-transcending vaccine.</div><div class="figure-wrap"><header><div class="label">Fig 5</div></header><figure id="F5" class="graphic"><img src="/cms/10.1128/IAI.00206-12/asset/96774aea-6bb3-4f6e-afba-232dbc643e89/assets/graphic/zii9990997380005.jpeg" /><figcaption><span class="heading">Fig 5</span> Binding-inhibitory anti-PvDBPII MAbs target epitopes on PvDBPII SD3. (A) MAbs 2C6, 2D10, 2F12, 2H2, and 3C9 block the binding of recombinant PvDBPII to erythrocytes in a dose-dependent fashion, whereas MAbs 3D10, 1D2, and 3A4 do not. (B) The five blocking MAbs recognized constructs containing SD3 but not recombinant constructs that contain SD1+2 or SD2. Two of the nonblocking MAbs, 3D10 and 1D2, recognize constructs containing full-length SD2 (1D2) or SD1 (3D10), indicating that part or all of the epitopes recognized by the MAbs are contained in these subdomains. MAbs 3A4 and 2A6 show poor reactivity to any of the recombinant subdomain constructs. Percent inhibition was measured as described in Materials and Methods. The experiment was repeated once with similar results.</figcaption></figure></div><div role="paragraph">To confirm the binding domain targeted by the MAbs, we generated five PvDBPII subdomain constructs (SD1, SD1+2, SD1+2+3, SD2+3, and SD3) by cloning the genes encoding the various subdomains of PvDBPII into phagemid pHEN-H6 for display on the surface of an M13 bacteriophage. The constructs were each expressed as chimeras and fused with the pIII minor coat protein of the phage, and the concentrations were normalized (<a href="#F6">Fig. 6A</a>). None of the PvDBPII constructs reacted with IgG control MAb 1F9 at the highest concentration of phage used in the same ELISA. Eight of the nine MAbs tested bound well to the three constructs possessing SD3 (<a href="#F6">Fig. 6B</a>) and bound poorly to other constructs. The MAbs that blocked the binding of PvDBPII to erythrocytes (2C6, 3C9, 2D10, and 2H2) again only recognized constructs containing SD3. This confirmed that epitopes for these MAbs consist mainly of sequences contained within SD3. In contrast, MAb 3D10 again bound well to constructs containing SD1, confirming our previous results. Interestingly, nonblocking MAbs 3A4 and 2A6 failed to recognize <span class="named-content" data-type="genus-species">E. coli</span>-expressed and refolded constructs (<a href="#F5">Fig. 5</a>) yet recognized similar constructs generated using the phagemid system (<a href="#F6">Fig. 6</a>), suggesting that these two expression systems do not generate identically configured proteins. In conclusion, these results show that binding-inhibitory MAbs recognize residues in SD3.</div><div class="figure-wrap"><header><div class="label">Fig 6</div></header><figure id="F6" class="graphic"><img src="/cms/10.1128/IAI.00206-12/asset/c4531c2f-6843-4a87-8f72-25cb55cae819/assets/graphic/zii9990997380006.jpeg" /><figcaption><span class="heading">Fig 6</span> (A) Phagemid expression system used to generate different subdomains of PvDBPII. (B) MAbs that block PvDBPII-erythrocyte binding recognize only SD3-containing constructs, and noninhibitory MAb 3D10 binds preferentially to SD1-containing constructs.</figcaption></figure></div></section><section id="sec-3-6"><h3>Blocking activity of anti-SD3 MAbs against PvDBPII can be strain transcending.</h3><div role="paragraph">We next examined whether the specific MAbs that block PvDBPII binding and target epitopes on SD3 are strain specific or strain transcending. Of the four MAbs with the greatest blocking activity, three showed blocking activity similar to that of the three PvDBPII variants examined, whereas MAb 2C6 showed comparatively poor blocking of the AH variant (<a href="#F7">Fig. 7</a>). The SalI variant differed from the AH and O variants at three and two residues, respectively, in the SD3+ construct, one at position N417K (in SD2 but included in SD3+), two in SD3 at positions W437R and I503K (with AH), and one in SD3 at position S447K (with O). Therefore, MAb 2C6 likely recognizes an epitope that contains one or more of these polymorphisms. This suggests that most of the binding-inhibitory MAbs tested recognize epitopes that are strain transcendent.</div><div class="figure-wrap"><header><div class="label">Fig 7</div></header><figure id="F7" class="graphic"><img src="/cms/10.1128/IAI.00206-12/asset/e5233d3b-996c-40d5-941b-5958a9cd5f91/assets/graphic/zii9990997380007.jpeg" /><figcaption><span class="heading">Fig 7</span> MAbs that block binding of PvDBPII to human erythrocytes and recognize epitopes on SD3 are generally strain transcending. The abilities of four MAbs to inhibit the binding of three variants of PvDBPII are shown. Percent inhibition was measured as described in Materials and Methods.</figcaption></figure></div></section><section id="sec-3-7"><h3>The lysines of PvDBPII are required for binding to erythrocytes.</h3><div role="paragraph">Based on a previous report by Singh et al. (<a href="#B32" role="doc-biblioref" data-xml-rid="B32">32</a>) that the minimum domain for the binding of DBL3x to CSA involves lysine-rich regions of SD3, we chemically modified lysines for both PvDBPII and SD3 by reductive methylation of free amino groups. This modification of PvDBPII reduced its binding to erythrocytes by 60%, compared with that of the unmethylated protein, and reduced that of SD3 by 85% (<a href="#F8">Fig. 8</a>). Methylation of lysines does not change the charge on the lysine side chains but increases both hydrophobicity and steric bulk and can affect protein-protein interactions if the lysines are on an interacting surface (<a href="#B38" role="doc-biblioref" data-xml-rid="B38">38</a>). This demonstrates that the lysines present on SD3 are crucial for binding to erythrocytes.</div><div class="figure-wrap"><header><div class="label">Fig 8</div></header><figure id="F8" class="graphic"><img src="/cms/10.1128/IAI.00206-12/asset/daa89f1d-d1bf-42ca-9a9f-4d759463ca10/assets/graphic/zii9990997380008.jpeg" /><figcaption><span class="heading">Fig 8</span> Methylation of lysines on PvDBPII and SD3 impaired binding to Duffy<sup>+</sup> erythrocytes. Recombinant PvDBPII and SD3 were methylated as described in Materials and Methods, and the binding of 1 Î¼g of the recombinant protein to 10<sup>6</sup> Duffy<sup>+</sup> erythrocytes was assayed by flow cytometry. Assays were performed in triplicate, and values are means Â± standard deviations. Experiments were repeated at concentrations of 0.5 and 0.25 Î¼g/ml with similar results. Methylation of recombinant proteins did not affect solubility. MFI, mean fluorescence index.</figcaption></figure></div></section><section id="sec-3-8"><h3>Human sera that contain highly BIAbs to PvDBPII also block binding of SD3 to Fy.</h3><div role="paragraph">To determine whether previously characterized naturally acquired BIAbs to PvDBPII (<a href="#B22" role="doc-biblioref" data-xml-rid="B22">22</a>) also target SD3, blocking experiments were performed in parallel with PvDBPII and SD3 (<a href="#F9">Fig. 9</a>). Overall BIAbs showed greater blocking of PvDBPII than of SD3 binding to Fy; however, there was a good correlation between the blocking activities of the two constructions. Notably, in some samples, the blocking activity directed against SD3 was comparable to that against full-length PvDBPII, suggesting that the residues in PvDBPII targeted by naturally acquired BIAbs likely occur within SD3.</div><div class="figure-wrap"><header><div class="label">Fig 9</div></header><figure id="F9" class="graphic"><img src="/cms/10.1128/IAI.00206-12/asset/229fe36f-6c49-474f-99b3-82c4445e1c7c/assets/graphic/zii9990997380009.jpeg" /><figcaption><span class="heading">Fig 9</span> Testing of the relationship of the binding-inhibitory activity of sera from 18 Papua New Guinean subjects previously exposed to <span class="named-content" data-type="genus-species">P. vivax</span> directed to recombinant PvDBPII and SD3 binding to Duffy<sup>+</sup> erythrocytes by flow cytometry. Sera were used at a 1:10 dilution. Percent inhibition is the average of duplicate assays of the same sample calculated as described in Materials and Methods. The correlation coefficient (<i>r</i><sup>2</sup>) determined by linear regression analysis is 0.77 (<i>P</i> &lt; 0.0001).</figcaption></figure></div></section></section><section id="sec-4" data-type="discussion"><h2>DISCUSSION</h2><div role="paragraph">PvDBPII is the leading <span class="named-content" data-type="genus-species">P. vivax</span> blood stage vaccine candidate, and yet, studies clearly demonstrate that PvDBPII ligand is polymorphic (<a href="#B10" role="doc-biblioref" data-xml-rid="B10">10</a>, <a href="#B36" role="doc-biblioref" data-xml-rid="B36">36</a>, <a href="#B40" role="doc-biblioref" data-xml-rid="B40">40</a>) and individuals repeatedly exposed to <span class="named-content" data-type="genus-species">P. vivax</span> often fail to develop antibody responses to PvDBPII (<a href="#B12" role="doc-biblioref" data-xml-rid="B12">12</a>), suggesting that naturally exposed ligand is poorly immunogenic. Indeed, PvDBPII demonstrates the hallmarks of immune evasion properties of other microbial ligands under strong immune selection where the most polymorphic region of PvDBPII lies within central SD2, which also contains the residues of the ligand domain most critical for binding to Fy (<a href="#F1">Fig. 1</a>) (<a href="#B5" role="doc-biblioref" data-xml-rid="B5">5</a>, <a href="#B37" role="doc-biblioref" data-xml-rid="B37">37</a>, <a href="#B41" role="doc-biblioref" data-xml-rid="B41">41</a>). Indeed, the failure of two leading <span class="named-content" data-type="genus-species">P. falciparum</span> blood stage vaccine candidates to protect against clinical malaria can be attributed to the limited strain-specific response elicited by vaccination with a monovalent vaccine (<a href="#B15" role="doc-biblioref" data-xml-rid="B15">15</a>). Several basic approaches have been used to tackle this problem. The first is to immunize with multiple common variants of the molecule, as has been done with pneumococcal vaccine (<a href="#B3" role="doc-biblioref" data-xml-rid="B3">3</a>, <a href="#B40" role="doc-biblioref" data-xml-rid="B40">40</a>) and in the clinical testing of some other blood stage <span class="named-content" data-type="genus-species">P. falciparum</span> vaccine candidates (<a href="#B27" role="doc-biblioref" data-xml-rid="B27">27</a>). Therefore, multiple PvDBPII alleles may be required in a vaccine for broader coverage. This is expensive, it is difficult to produce a consistent formulation, and this approach may lead to selection for uncommon variants. Another alternative, although more challenging, approach is to focus the immune response on conserved epitope targets of strain-transcending neutralizing immunity. One way to achieve this goal is to eliminate the immunodominant variant epitopes responsible for strain-specific responses (<a href="#B25" role="doc-biblioref" data-xml-rid="B25">25</a>). Another way to accomplish this goal has been to identify a minimal motif within the vaccine candidate that is conserved yet can elicit protective Abs that functionally neutralize the native intact target antigen. In this study, we show that a reduced portion of the PvDBPII ligand domain, SD3+, represents such a potential minimal motif capable of eliciting a broadly neutralizing binding-inhibitory antibody response against diverse alleles of PvDBPII. These observations are based on an <i>in vitro</i> binding assay, and it is unknown whether these inhibitory epitopes are accessible in the native protein on the parasite surface. This will require confirmation in short-term <span class="named-content" data-type="genus-species">P. vivax</span> invasion assays (<a href="#B16" role="doc-biblioref" data-xml-rid="B16">16</a>, <a href="#B29" role="doc-biblioref" data-xml-rid="B29">29</a>).</div><div role="paragraph">Here we also show that the third discrete subdomain of PvDBPII, SD3, is also important for PvDBPII engagement of Fy. Naturally acquired BIAbs are directed to SD3, and artificially induced Abs to SD3 block the binding of full-length PvDBPII. We also show that binding-inhibitory MAbs raised to full-length PvDBPII target epitopes in SD3. Thus, SD3 plays an important role in binding to Fy and can elicit BIAbs. SD3 is more conserved than highly polymorphic SD2 and could constitute a strain-transcending subunit vaccine candidate. It is important to note that in prior studies in which different fragments of PvDBPII were expressed on the surface of COS7 cells, constructs that contained primarily SD3 failed to bind erythrocytes (<a href="#B28" role="doc-biblioref" data-xml-rid="B28">28</a>, <a href="#B30" role="doc-biblioref" data-xml-rid="B30">30</a>). This discrepancy from our findings may arise from the different expression systems used and the different PvDBPII fragments expressed. In the present study, constructs were based on subdomains determined by the closely homologous crystal structure of <span class="named-content" data-type="genus-species">P. knowlesi</span> (<a href="#B34" role="doc-biblioref" data-xml-rid="B34">34</a>), whereas the earlier constructs (<a href="#B28" role="doc-biblioref" data-xml-rid="B28">28</a>, <a href="#B30" role="doc-biblioref" data-xml-rid="B30">30</a>) were based on locations of conserved cysteine residues and included sequences from <span class="named-content" data-type="genus-species">P. knowlesi</span>.</div><div role="paragraph">Supporting the possibility that SD3 may contribute to a strain-transcending vaccine is the finding that rats immunized with recombinant proteins that contained SD3 only or SD3 plus a 24-aa sequence of SD2 (SD3+) generated strain-transcending BIAbs. In contrast, full-length PvDBPII generated higher titers of BIAbs but the blocking activity was partially strain specific. It is possible that the expression of the subdomain constructs unmasked epitopes near critical binding residues, which were otherwise hidden in the full-length molecule. The drawback is loss of immunogenicity. This may occur because full-length PvDBPII contains strong B- and T-cell epitopes primarily in SD2 and SD1, respectively (<a href="#B41" role="doc-biblioref" data-xml-rid="B41">41</a>). Thus, future studies may aim to construct a recombinant molecule based predominantly on SD3 that includes the strong T-cell epitopes that enhance its immunogenicity.</div><div role="paragraph">The poor binding of constructs containing SD1+2 and SD2 to human erythrocytes, compared to that of those that contain SD3, suggests the importance of the SD3 subdomain in presenting PvDBPII to Fy. It is also possible that the expression and refolding of SD1+2 and SD2 does not acquire the correct conformation necessary for optimal binding to Fy. Constructs that contained SD2 but not SD3 elicited poor blocking Abs in rats, suggesting that SD2 may be poorly immunogenic or that functional epitopes are cryptic or lack a fixed conformation. These findings are consistent with three-dimensional structure studies of the DBL domains showing that intersubdomain hinge-like regions lack rigid structural properties even though they contain residues important for erythrocyte binding (<a href="#B5" role="doc-biblioref" data-xml-rid="B5">5</a>, <a href="#B19" role="doc-biblioref" data-xml-rid="B19">19</a>, <a href="#B32" role="doc-biblioref" data-xml-rid="B32">32</a>, <a href="#B34" role="doc-biblioref" data-xml-rid="B34">34</a>). This suggests that contact-induced conformational changes may occur as PvDBPII engages Fy. It would not be unexpected that such a conformational induced fit led to the exposure of a cryptic recognition site for a second receptor.</div><div role="paragraph">The results of our present study have led us to modify our interpretation of the recently published crystal structure, which shows that PvDBPII forms a dimer upon receptor engagement (<a href="#B5" role="doc-biblioref" data-xml-rid="B5">5</a>). According to this model, the dimer forms a binding groove for Fy. The cocrystallization was performed with ammonium phosphate or sodium selenate as the nidus for dimerization, without the N-terminal region of Fy that contains the binding domain for PvDBPII (<a href="#B5" role="doc-biblioref" data-xml-rid="B5">5</a>). The purpose of using selenate was structure determination by anomalous dispersion. Phosphate and selenate are structurally similar to sulfate. A previous study, using a protein construct comprising the N-terminal 60 aa of Fy linked to human IgG heavy chain, indicated that sulfation of Tyr41 in the N-terminal portion of Fy was critical for binding to PvDBPII (<a href="#B8" role="doc-biblioref" data-xml-rid="B8">8</a>). Whether this chimeric construct fully represents native Fy on erythrocytes is uncertain. Epitopes of naturally acquired Abs (<a href="#B9" role="doc-biblioref" data-xml-rid="B9">9</a>) map to the dimer interface and the Fy-binding groove (<a href="#B5" role="doc-biblioref" data-xml-rid="B5">5</a>), suggesting that the mechanism of action is interference with dimerization. This dimer interface and Fy binding groove is different from the predicted binding site previously reported by Singh et al. (<a href="#B34" role="doc-biblioref" data-xml-rid="B34">34</a>). SD3 is located away from the dimer interface. The data presented in this study demonstrate that anti-SD3 Abs inhibit DBPII-Fy binding and the inhibitory mouse MAbs map to SD3. The epitope specificity of mouse MAbs was different from that of Abs generated by natural infection. This brings into question the mechanisms of action of anti-DBP neutralizing Abs. Cocrystallization of DBPII along with inhibitory Abs will help to explain better how inhibitory Abs work.</div><div role="paragraph">Other studies of <span class="named-content" data-type="genus-species">P. falciparum</span> binding ligands with high homology to PvDBPII show an essential role for SD3 in binding to their receptors (<a href="#B32" role="doc-biblioref" data-xml-rid="B32">32</a>). For example, the <span class="named-content" data-type="genus-species">P. falciparum</span> DBL3x domain of VAR2CSA (a member of the PfEMP1 family) has a structure similar to that of PvDBPII, with three similar subdomains that bind CSA. Cocrystallization of the DBL3x domain with CSA shows that SD3 is essential for binding (<a href="#B31" role="doc-biblioref" data-xml-rid="B31">31</a>). Important for this binding are clusters of positively charged residues (arginine and lysine) on SD2 and especially SD3. SD2 and SD3 of PvDBPII (pI 9.4) both contain clusters of 15 lysine and arginine residues similar to the orthologous subdomains for the DBL3x domain that may contribute to binding to the overall negatively charged N-terminal region of Fy (pI 3.6, <a href="#F1">Fig. 1</a>). This possibility is supported by the finding that methylation of lysines on PvDBPII, which impairs hydrogen bonding capacity and increases steric bulk, decreased its binding to Fy by 60% (<a href="#F8">Fig. 8</a>). This is most pronounced for SD3. Thus, we propose that SD3 participates in an initial low-affinity, electrostatic-charge-mediated binding to Fy, followed by a higher-affinity interaction, possibly by the formation of a dimer that creates a single channel enveloping the N-terminal region of Fy, as suggested by the recent crystal structure of PvDBPII (<a href="#B5" role="doc-biblioref" data-xml-rid="B5">5</a>).</div><div role="paragraph">In conclusion, SD3 of PvDBPII plays a critical role in binding to the Duffy antigen on erythrocytes and it can elicit BIAbs in both rats and humans. The importance of this observation is that SD3 is relatively conserved compared to other subdomains of PvDBPII, which are highly polymorphic and in themselves poorly immunogenic. This suggests that a subunit vaccine construct that predominantly includes SD3 linked to strong universal T-cell epitopes may be considered as an alternative to PvDBPII to produce strain-transcending immunity.</div></section><section id="acknowledgments" role="doc-acknowledgments"><h2>ACKNOWLEDGMENTS</h2><div data-type="financial-disclosure" role="paragraph">This work was supported, in part, by the Veterans Affairs Research Service and NIH grants R01 A1064478 and AI33656.</div><div role="paragraph">We appreciate the help of Jane Haas in constructing the models of PvDBPII. We thank Amy McHenry for critical reading of the manuscript. We are grateful to all of the volunteers and patients recruited in this study.</div></section></div></section><section id="backmatter" data-extent="backmatter"><div class="core-container"><section id="bibliography" role="doc-bibliography"><h2>REFERENCES</h2><div class="labeled" role="doc-biblioentry"><div class="label">1.</div><div id="B1" class="citations"><div class="citation"><div class="citation-content">Adams JH, Blair PL, Kaneko O, and Peterson DS. 2001. An expanding ebl family of Plasmodium falciparum. <em>Trends Parasitol.</em> 17:297â299.</div><div class="external-links"><div><a href="https://doi.org/10.1016/S1471-4922(01)01948-1">Crossref</a></div><div><a href="https://www.ncbi.nlm.nih.gov/pubmed/11378038">PubMed</a></div><div><a href="http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&amp;DestApp=WOS_CPL&amp;UsrCustomerID=5e3815c904498985e796fc91436abd9a&amp;SrcAuth=atyponcel&amp;SrcApp=literatum&amp;DestLinkType=FullRecord&amp;KeyUT=000170180100013">ISI</a></div><div><a href="https://scholar.google.com/scholar_lookup?title=An+expanding+ebl+family+of+Plasmodium+falciparum&amp;author=JH+Adams&amp;author=PL+Blair&amp;author=O+Kaneko&amp;author=DS+Peterson&amp;publication_year=2001&amp;pages=297-299&amp;doi=10.1016%2FS1471-4922%2801%2901948-1&amp;pmid=11378038">Google Scholar</a></div></div></div></div></div><div class="labeled" role="doc-biblioentry"><div class="label">2.</div><div id="B2" class="citations"><div class="citation"><div class="citation-content">Adams JH et al. 1992. A family of erythrocyte binding proteins of malaria parasites. <em>Proc. Natl. Acad. Sci. U. S. A.</em> 89:7085â7089.</div><div class="external-links"><div><a href="https://doi.org/10.1073/pnas.89.15.7085">Crossref</a></div><div><a href="https://www.ncbi.nlm.nih.gov/pubmed/1496004">PubMed</a></div><div><a href="http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&amp;DestApp=WOS_CPL&amp;UsrCustomerID=5e3815c904498985e796fc91436abd9a&amp;SrcAuth=atyponcel&amp;SrcApp=literatum&amp;DestLinkType=FullRecord&amp;KeyUT=A1992JF85600088">ISI</a></div><div><a href="https://scholar.google.com/scholar_lookup?title=A+family+of+erythrocyte+binding+proteins+of+malaria+parasites&amp;author=JH+Adams&amp;publication_year=1992&amp;pages=7085-7089&amp;doi=10.1073%2Fpnas.89.15.7085&amp;pmid=1496004">Google Scholar</a></div></div></div></div></div><div class="labeled" role="doc-biblioentry"><div class="label">3.</div><div id="B3" class="citations"><div class="citation"><div class="citation-content">Ampudia E, Patarroyo MA, Patarroyo ME, and Murillo LA. 1996. Genetic polymorphism of the Duffy receptor binding domain of Plasmodium vivax in Colombian wild isolates. <em>Mol. Biochem. Parasitol.</em> 78:269â272.</div><div class="external-links"><div><a href="https://doi.org/10.1016/S0166-6851(96)02611-4">Crossref</a></div><div><a href="https://www.ncbi.nlm.nih.gov/pubmed/8813697">PubMed</a></div><div><a href="http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&amp;DestApp=WOS_CPL&amp;UsrCustomerID=5e3815c904498985e796fc91436abd9a&amp;SrcAuth=atyponcel&amp;SrcApp=literatum&amp;DestLinkType=FullRecord&amp;KeyUT=A1996UW15900026">ISI</a></div><div><a href="https://scholar.google.com/scholar_lookup?title=Genetic+polymorphism+of+the+Duffy+receptor+binding+domain+of+Plasmodium+vivax+in+Colombian+wild+isolates&amp;author=E+Ampudia&amp;author=MA+Patarroyo&amp;author=ME+Patarroyo&amp;author=LA+Murillo&amp;publication_year=1996&amp;pages=269-272&amp;doi=10.1016%2FS0166-6851%2896%2902611-4&amp;pmid=8813697">Google Scholar</a></div></div></div></div></div><div class="labeled" role="doc-biblioentry"><div class="label">4.</div><div id="B4" class="citations"><div class="citation"><div class="citation-content">Barnwell JW, Nichols ME, and Rubinstein P. 1989. In vitro evaluation of the role of the Duffy blood group in erythrocyte invasion by Plasmodium vivax. <em>J. Exp. Med.</em> 169:1795â1802.</div><div class="external-links"><div><a href="https://doi.org/10.1084/jem.169.5.1795">Crossref</a></div><div><a href="https://www.ncbi.nlm.nih.gov/pubmed/2469769">PubMed</a></div><div><a href="https://scholar.google.com/scholar_lookup?title=In+vitro+evaluation+of+the+role+of+the+Duffy+blood+group+in+erythrocyte+invasion+by+Plasmodium+vivax&amp;author=JW+Barnwell&amp;author=ME+Nichols&amp;author=P+Rubinstein&amp;publication_year=1989&amp;pages=1795-1802&amp;doi=10.1084%2Fjem.169.5.1795&amp;pmid=2469769">Google Scholar</a></div></div></div></div></div><div class="labeled" role="doc-biblioentry"><div class="label">5.</div><div id="B5" class="citations"><div class="citation"><div class="citation-content">Batchelor JD, Zahm JA, and Tolia NH. 2011. Dimerization of Plasmodium vivax DBP is induced upon receptor binding and drives recognition of DARC. <em>Nat. Struct. Mol. Biol.</em> 18:908â914.</div><div class="external-links"><div><a href="https://doi.org/10.1038/nsmb.2088">Crossref</a></div><div><a href="https://www.ncbi.nlm.nih.gov/pubmed/21743458">PubMed</a></div><div><a href="http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&amp;DestApp=WOS_CPL&amp;UsrCustomerID=5e3815c904498985e796fc91436abd9a&amp;SrcAuth=atyponcel&amp;SrcApp=literatum&amp;DestLinkType=FullRecord&amp;KeyUT=000293457200010">ISI</a></div><div><a href="https://scholar.google.com/scholar_lookup?title=Dimerization+of+Plasmodium+vivax+DBP+is+induced+upon+receptor+binding+and+drives+recognition+of+DARC&amp;author=JD+Batchelor&amp;author=JA+Zahm&amp;author=NH+Tolia&amp;publication_year=2011&amp;pages=908-914&amp;doi=10.1038%2Fnsmb.2088&amp;pmid=21743458">Google Scholar</a></div></div></div></div></div><div class="labeled" role="doc-biblioentry"><div class="label">6.</div><div id="B6" class="citations"><div class="citation"><div class="citation-content">Chitnis CE, Chaudhuri A, Horuk R, Pogo AO, and Miller LH. 1996. The domain on the Duffy blood group antigen for binding Plasmodium vivax and P. knowlesi malarial parasites to erythrocytes. <em>J. Exp. Med.</em> 184:1531â1536.</div><div class="external-links"><div><a href="https://doi.org/10.1084/jem.184.4.1531">Crossref</a></div><div><a href="https://www.ncbi.nlm.nih.gov/pubmed/8879225">PubMed</a></div><div><a href="http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&amp;DestApp=WOS_CPL&amp;UsrCustomerID=5e3815c904498985e796fc91436abd9a&amp;SrcAuth=atyponcel&amp;SrcApp=literatum&amp;DestLinkType=FullRecord&amp;KeyUT=A1996VP23000036">ISI</a></div><div><a href="https://scholar.google.com/scholar_lookup?title=The+domain+on+the+Duffy+blood+group+antigen+for+binding+Plasmodium+vivax+and+P.+knowlesi+malarial+parasites+to+erythrocytes&amp;author=CE+Chitnis&amp;author=A+Chaudhuri&amp;author=R+Horuk&amp;author=AO+Pogo&amp;author=LH+Miller&amp;publication_year=1996&amp;pages=1531-1536&amp;doi=10.1084%2Fjem.184.4.1531&amp;pmid=8879225">Google Scholar</a></div></div></div></div></div><div class="labeled" role="doc-biblioentry"><div class="label">7.</div><div id="B7" class="citations"><div class="citation"><div class="citation-content">Chitnis CE and Miller LH. 1994. Identification of the erythrocyte binding domains of Plasmodium vivax and Plasmodium knowlesi proteins involved in erythrocyte invasion. <em>J. Exp. Med.</em> 180:497â506.</div><div class="external-links"><div><a href="https://doi.org/10.1084/jem.180.2.497">Crossref</a></div><div><a href="https://www.ncbi.nlm.nih.gov/pubmed/8046329">PubMed</a></div><div><a href="http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&amp;DestApp=WOS_CPL&amp;UsrCustomerID=5e3815c904498985e796fc91436abd9a&amp;SrcAuth=atyponcel&amp;SrcApp=literatum&amp;DestLinkType=FullRecord&amp;KeyUT=A1994NZ38500009">ISI</a></div><div><a href="https://scholar.google.com/scholar_lookup?title=Identification+of+the+erythrocyte+binding+domains+of+Plasmodium+vivax+and+Plasmodium+knowlesi+proteins+involved+in+erythrocyte+invasion&amp;author=CE+Chitnis&amp;author=LH+Miller&amp;publication_year=1994&amp;pages=497-506&amp;doi=10.1084%2Fjem.180.2.497&amp;pmid=8046329">Google Scholar</a></div></div></div></div></div><div class="labeled" role="doc-biblioentry"><div class="label">8.</div><div id="B8" class="citations"><div class="citation"><div class="citation-content">Choe H et al. 2005. Sulphated tyrosines mediate association of chemokines and Plasmodium vivax Duffy binding protein with the Duffy antigen/receptor for chemokines (DARC). <em>Mol. Microbiol.</em> 55:1413â1422.</div><div class="external-links"><div><a href="https://doi.org/10.1111/j.1365-2958.2004.04478.x">Crossref</a></div><div><a href="https://www.ncbi.nlm.nih.gov/pubmed/15720550">PubMed</a></div><div><a href="https://scholar.google.com/scholar_lookup?title=Sulphated+tyrosines+mediate+association+of+chemokines+and+Plasmodium+vivax+Duffy+binding+protein+with+the+Duffy+antigen%2Freceptor+for+chemokines+%28DARC%29&amp;author=H+Choe&amp;publication_year=2005&amp;pages=1413-1422&amp;doi=10.1111%2Fj.1365-2958.2004.04478.x&amp;pmid=15720550">Google Scholar</a></div></div></div></div></div><div class="labeled" role="doc-biblioentry"><div class="label">9.</div><div id="B9" class="citations"><div class="citation"><div class="citation-content">Chootong P et al. 2010. Mapping epitopes of the <span class="named-content" data-type="genus-species">Plasmodium vivax</span> Duffy binding protein with naturally acquired inhibitory antibodies. <em>Infect. Immun.</em> 78:1089â1095.</div><div class="external-links"><div><a href="https://doi.org/10.1128/IAI.01036-09">Crossref</a></div><div><a href="https://www.ncbi.nlm.nih.gov/pubmed/20008533">PubMed</a></div><div><a href="http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&amp;DestApp=WOS_CPL&amp;UsrCustomerID=5e3815c904498985e796fc91436abd9a&amp;SrcAuth=atyponcel&amp;SrcApp=literatum&amp;DestLinkType=FullRecord&amp;KeyUT=000274654200021">ISI</a></div><div><a href="https://scholar.google.com/scholar_lookup?title=Mapping+epitopes+of+the+Plasmodium+vivax+Duffy+binding+protein+with+naturally+acquired+inhibitory+antibodies&amp;author=P+Chootong&amp;publication_year=2010&amp;pages=1089-1095&amp;doi=10.1128%2FIAI.01036-09&amp;pmid=20008533">Google Scholar</a></div></div></div></div></div><div class="labeled" role="doc-biblioentry"><div class="label">10.</div><div id="B10" class="citations"><div class="citation"><div class="citation-content">Cole-Tobian J and King CL. 2003. Diversity and natural selection in Plasmodium vivax Duffy binding protein gene. <em>Mol. Biochem. Parasitol.</em> 127:121â132.</div><div class="external-links"><div><a href="https://doi.org/10.1016/S0166-6851(02)00327-4">Crossref</a></div><div><a href="https://www.ncbi.nlm.nih.gov/pubmed/12672521">PubMed</a></div><div><a href="http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&amp;DestApp=WOS_CPL&amp;UsrCustomerID=5e3815c904498985e796fc91436abd9a&amp;SrcAuth=atyponcel&amp;SrcApp=literatum&amp;DestLinkType=FullRecord&amp;KeyUT=000182385200003">ISI</a></div><div><a href="https://scholar.google.com/scholar_lookup?title=Diversity+and+natural+selection+in+Plasmodium+vivax+Duffy+binding+protein+gene&amp;author=J+Cole-Tobian&amp;author=CL+King&amp;publication_year=2003&amp;pages=121-132&amp;doi=10.1016%2FS0166-6851%2802%2900327-4&amp;pmid=12672521">Google Scholar</a></div></div></div></div></div><div class="labeled" role="doc-biblioentry"><div class="label">11.</div><div id="B11" class="citations"><div class="citation"><div class="citation-content">Cole-Tobian JL et al. 2002. Age-acquired immunity to a Plasmodium vivax invasion ligand, the Duffy binding protein. <em>J. Infect. Dis.</em> 186:531â539.</div><div class="external-links"><div><a href="https://doi.org/10.1086/341776">Crossref</a></div><div><a href="https://www.ncbi.nlm.nih.gov/pubmed/12195381">PubMed</a></div><div><a href="https://scholar.google.com/scholar_lookup?title=Age-acquired+immunity+to+a+Plasmodium+vivax+invasion+ligand%2C+the+Duffy+binding+protein&amp;author=JL+Cole-Tobian&amp;publication_year=2002&amp;pages=531-539&amp;doi=10.1086%2F341776&amp;pmid=12195381">Google Scholar</a></div></div></div></div></div><div class="labeled" role="doc-biblioentry"><div class="label">12.</div><div id="B12" class="citations"><div class="citation"><div class="citation-content">Cole-Tobian JL, Michon P, Dabod E, Mueller I, and King CL. 2007. Dynamics of asymptomatic Plasmodium vivax infections and Duffy binding protein polymorphisms in relation to parasitemia levels in Papua New Guinean children. <em>Am. J. Trop. Med. Hyg.</em> 77:955â962.</div><div class="external-links"><div><a href="https://doi.org/10.4269/ajtmh.2007.77.955">Crossref</a></div><div><a href="https://www.ncbi.nlm.nih.gov/pubmed/17984360">PubMed</a></div><div><a href="https://scholar.google.com/scholar_lookup?title=Dynamics+of+asymptomatic+Plasmodium+vivax+infections+and+Duffy+binding+protein+polymorphisms+in+relation+to+parasitemia+levels+in+Papua+New+Guinean+children&amp;author=JL+Cole-Tobian&amp;author=P+Michon&amp;author=E+Dabod&amp;author=I+Mueller&amp;author=CL+King&amp;publication_year=2007&amp;pages=955-962&amp;doi=10.4269%2Fajtmh.2007.77.955&amp;pmid=17984360">Google Scholar</a></div></div></div></div></div><div class="labeled" role="doc-biblioentry"><div class="label">13.</div><div id="B13" class="citations"><div class="citation"><div class="citation-content">Cole-Tobian JL, Zimmerman PA, and King CL. 2007. High-throughput identification of the predominant malaria parasite clone in complex blood stage infections using a multi-SNP molecular haplotyping assay. <em>Am. J. Trop. Med. Hyg.</em> 76:12â19.</div><div class="external-links"><div><a href="https://doi.org/10.4269/ajtmh.2007.76.12">Crossref</a></div><div><a href="https://www.ncbi.nlm.nih.gov/pubmed/17255222">PubMed</a></div><div><a href="https://scholar.google.com/scholar_lookup?title=High-throughput+identification+of+the+predominant+malaria+parasite+clone+in+complex+blood+stage+infections+using+a+multi-SNP+molecular+haplotyping+assay&amp;author=JL+Cole-Tobian&amp;author=PA+Zimmerman&amp;author=CL+King&amp;publication_year=2007&amp;pages=12-19&amp;doi=10.4269%2Fajtmh.2007.76.12&amp;pmid=17255222">Google Scholar</a></div></div></div></div></div><div class="labeled" role="doc-biblioentry"><div class="label">14.</div><div id="B14" class="citations"><div class="citation"><div class="citation-content">Coley AM et al. 2006. The most polymorphic residue on <span class="named-content" data-type="genus-species">Plasmodium falciparum</span> apical membrane antigen 1 determines binding of an invasion-inhibitory antibody. <em>Infect. Immun.</em> 74:2628â2636.</div><div class="external-links"><div><a href="https://doi.org/10.1128/IAI.74.5.2628-2636.2006">Crossref</a></div><div><a href="https://www.ncbi.nlm.nih.gov/pubmed/16622199">PubMed</a></div><div><a href="http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&amp;DestApp=WOS_CPL&amp;UsrCustomerID=5e3815c904498985e796fc91436abd9a&amp;SrcAuth=atyponcel&amp;SrcApp=literatum&amp;DestLinkType=FullRecord&amp;KeyUT=000237311200015">ISI</a></div><div><a href="https://scholar.google.com/scholar_lookup?title=The+most+polymorphic+residue+on+Plasmodium+falciparum+apical+membrane+antigen+1+determines+binding+of+an+invasion-inhibitory+antibody&amp;author=AM+Coley&amp;publication_year=2006&amp;pages=2628-2636&amp;doi=10.1128%2FIAI.74.5.2628-2636.2006&amp;pmid=16622199">Google Scholar</a></div></div></div></div></div><div class="labeled" role="doc-biblioentry"><div class="label">15.</div><div id="B15" class="citations"><div class="citation"><div class="citation-content">Genton B et al. 2002. A recombinant blood-stage malaria vaccine reduces Plasmodium falciparum density and exerts selective pressure on parasite populations in a phase 1-2b trial in Papua New Guinea. <em>J. Infect. Dis.</em> 185:820â827.</div><div class="external-links"><div><a href="https://doi.org/10.1086/339342">Crossref</a></div><div><a href="https://www.ncbi.nlm.nih.gov/pubmed/11920300">PubMed</a></div><div><a href="http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&amp;DestApp=WOS_CPL&amp;UsrCustomerID=5e3815c904498985e796fc91436abd9a&amp;SrcAuth=atyponcel&amp;SrcApp=literatum&amp;DestLinkType=FullRecord&amp;KeyUT=000174210200013">ISI</a></div><div><a href="https://scholar.google.com/scholar_lookup?title=A+recombinant+blood-stage+malaria+vaccine+reduces+Plasmodium+falciparum+density+and+exerts+selective+pressure+on+parasite+populations+in+a+phase+1-2b+trial+in+Papua+New+Guinea&amp;author=B+Genton&amp;publication_year=2002&amp;pages=820-827&amp;doi=10.1086%2F339342&amp;pmid=11920300">Google Scholar</a></div></div></div></div></div><div class="labeled" role="doc-biblioentry"><div class="label">16.</div><div id="B16" class="citations"><div class="citation"><div class="citation-content">Grimberg BT et al. 2007. Plasmodium vivax invasion of human erythrocytes inhibited by antibodies directed against the Duffy binding protein. <em>PLoS Med.</em> 4:e337. doi:</div><div class="external-links"><div><a href="https://doi.org/10.1371/journal.pmed.0040337">Crossref</a></div><div><a href="https://www.ncbi.nlm.nih.gov/pubmed/18092885">PubMed</a></div><div><a href="http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&amp;DestApp=WOS_CPL&amp;UsrCustomerID=5e3815c904498985e796fc91436abd9a&amp;SrcAuth=atyponcel&amp;SrcApp=literatum&amp;DestLinkType=FullRecord&amp;KeyUT=000251874600016">ISI</a></div><div><a href="https://scholar.google.com/scholar_lookup?title=Plasmodium+vivax+invasion+of+human+erythrocytes+inhibited+by+antibodies+directed+against+the+Duffy+binding+protein&amp;author=BT+Grimberg&amp;publication_year=2007&amp;pages=e337&amp;doi=10.1371%2Fjournal.pmed.0040337&amp;pmid=18092885">Google Scholar</a></div></div></div></div></div><div class="labeled" role="doc-biblioentry"><div class="label">17.</div><div id="B17" class="citations"><div class="citation"><div class="citation-content">Hans D et al. 2005. Mapping binding residues in the Plasmodium vivax domain that binds Duffy antigen during red cell invasion. <em>Mol. Microbiol.</em> 55:1423â1434.</div><div class="external-links"><div><a href="https://doi.org/10.1111/j.1365-2958.2005.04484.x">Crossref</a></div><div><a href="https://www.ncbi.nlm.nih.gov/pubmed/15720551">PubMed</a></div><div><a href="http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&amp;DestApp=WOS_CPL&amp;UsrCustomerID=5e3815c904498985e796fc91436abd9a&amp;SrcAuth=atyponcel&amp;SrcApp=literatum&amp;DestLinkType=FullRecord&amp;KeyUT=000227086300011">ISI</a></div><div><a href="https://scholar.google.com/scholar_lookup?title=Mapping+binding+residues+in+the+Plasmodium+vivax+domain+that+binds+Duffy+antigen+during+red+cell+invasion&amp;author=D+Hans&amp;publication_year=2005&amp;pages=1423-1434&amp;doi=10.1111%2Fj.1365-2958.2005.04484.x&amp;pmid=15720551">Google Scholar</a></div></div></div></div></div><div class="labeled" role="doc-biblioentry"><div class="label">18.</div><div id="B18" class="citations"><div class="citation"><div class="citation-content">Haynes JD et al. 1988. Receptor-like specificity of a Plasmodium knowlesi malarial protein that binds to Duffy antigen ligands on erythrocytes. <em>J. Exp. Med.</em> 167:1873â1881.</div><div class="external-links"><div><a href="https://doi.org/10.1084/jem.167.6.1873">Crossref</a></div><div><a href="https://www.ncbi.nlm.nih.gov/pubmed/2838562">PubMed</a></div><div><a href="http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&amp;DestApp=WOS_CPL&amp;UsrCustomerID=5e3815c904498985e796fc91436abd9a&amp;SrcAuth=atyponcel&amp;SrcApp=literatum&amp;DestLinkType=FullRecord&amp;KeyUT=A1988P187300011">ISI</a></div><div><a href="https://scholar.google.com/scholar_lookup?title=Receptor-like+specificity+of+a+Plasmodium+knowlesi+malarial+protein+that+binds+to+Duffy+antigen+ligands+on+erythrocytes&amp;author=JD+Haynes&amp;publication_year=1988&amp;pages=1873-1881&amp;doi=10.1084%2Fjem.167.6.1873&amp;pmid=2838562">Google Scholar</a></div></div></div></div></div><div class="labeled" role="doc-biblioentry"><div class="label">19.</div><div id="B19" class="citations"><div class="citation"><div class="citation-content">Howell DP et al. 2008. Mapping a common interaction site used by <span class="named-content" data-type="genus-species">Plasmodium falciparum</span> Duffy binding-like domains to bind diverse host receptors. <em>Mol. Microbiol.</em> 67:78â87.</div><div class="external-links"><div><a href="https://doi.org/10.1111/j.1365-2958.2007.06019.x">Crossref</a></div><div><a href="https://www.ncbi.nlm.nih.gov/pubmed/18047571">PubMed</a></div><div><a href="https://scholar.google.com/scholar_lookup?title=Mapping+a+common+interaction+site+used+by+Plasmodium+falciparum+Duffy+binding-like+domains+to+bind+diverse+host+receptors&amp;author=DP+Howell&amp;publication_year=2008&amp;pages=78-87&amp;doi=10.1111%2Fj.1365-2958.2007.06019.x&amp;pmid=18047571">Google Scholar</a></div></div></div></div></div><div class="labeled" role="doc-biblioentry"><div class="label">20.</div><div id="B20" class="citations"><div class="citation"><div class="citation-content">Jones TA, Zou JY, Cowan SW, and Kjeldgaard M. 1991. Improved methods for building protein models in electron density maps and the location of errors in these models. <em>Acta Crystallogr. A</em> 47(Pt 2):110â119.</div><div class="external-links"><div><a href="https://doi.org/10.1107/S0108767390010224">Crossref</a></div><div><a href="https://www.ncbi.nlm.nih.gov/pubmed/2025413">PubMed</a></div><div><a href="https://scholar.google.com/scholar_lookup?title=Improved+methods+for+building+protein+models+in+electron+density+maps+and+the+location+of+errors+in+these+models&amp;author=TA+Jones&amp;author=JY+Zou&amp;author=SW+Cowan&amp;author=M+Kjeldgaard&amp;publication_year=1991&amp;pages=110-119&amp;doi=10.1107%2FS0108767390010224&amp;pmid=2025413">Google Scholar</a></div></div></div></div></div><div class="labeled" role="doc-biblioentry"><div class="label">21.</div><div id="B21" class="citations"><div class="citation"><div class="citation-content">King CL et al. 2011. Fy(a)/Fy(b) antigen polymorphism in human erythrocyte Duffy antigen affects susceptibility to Plasmodium vivax malaria. <em>Proc. Natl. Acad. Sci. U. S. A.</em> 108:20113â20118.</div><div class="external-links"><div><a href="https://doi.org/10.1073/pnas.1109621108">Crossref</a></div><div><a href="https://www.ncbi.nlm.nih.gov/pubmed/22123959">PubMed</a></div><div><a href="https://scholar.google.com/scholar_lookup?title=Fy%28a%29%2FFy%28b%29+antigen+polymorphism+in+human+erythrocyte+Duffy+antigen+affects+susceptibility+to+Plasmodium+vivax+malaria&amp;author=CL+King&amp;publication_year=2011&amp;pages=20113-20118&amp;doi=10.1073%2Fpnas.1109621108&amp;pmid=22123959">Google Scholar</a></div></div></div></div></div><div class="labeled" role="doc-biblioentry"><div class="label">22.</div><div id="B22" class="citations"><div class="citation"><div class="citation-content">King CL et al. 2008. Naturally acquired Duffy-binding protein-specific binding inhibitory antibodies confer protection from blood-stage Plasmodium vivax infection. <em>Proc. Natl. Acad. Sci. U. S. A.</em> 105:8363â8368.</div><div class="external-links"><div><a href="https://doi.org/10.1073/pnas.0800371105">Crossref</a></div><div><a href="https://www.ncbi.nlm.nih.gov/pubmed/18523022">PubMed</a></div><div><a href="http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&amp;DestApp=WOS_CPL&amp;UsrCustomerID=5e3815c904498985e796fc91436abd9a&amp;SrcAuth=atyponcel&amp;SrcApp=literatum&amp;DestLinkType=FullRecord&amp;KeyUT=000257011200036">ISI</a></div><div><a href="https://scholar.google.com/scholar_lookup?title=Naturally+acquired+Duffy-binding+protein-specific+binding+inhibitory+antibodies+confer+protection+from+blood-stage+Plasmodium+vivax+infection&amp;author=CL+King&amp;publication_year=2008&amp;pages=8363-8368&amp;doi=10.1073%2Fpnas.0800371105&amp;pmid=18523022">Google Scholar</a></div></div></div></div></div><div class="labeled" role="doc-biblioentry"><div class="label">23.</div><div id="B23" class="citations"><div class="citation"><div class="citation-content">Miller LH, Mason SJ, Clyde DF, and McGinniss MH. 1976. The resistance factor to Plasmodium vivax in blacks. The Duffy-blood-group genotype, FyFy. <em>N. Engl. J. Med.</em> 295:302â304.</div><div class="external-links"><div><a href="https://doi.org/10.1056/NEJM197608052950602">Crossref</a></div><div><a href="https://www.ncbi.nlm.nih.gov/pubmed/778616">PubMed</a></div><div><a href="http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&amp;DestApp=WOS_CPL&amp;UsrCustomerID=5e3815c904498985e796fc91436abd9a&amp;SrcAuth=atyponcel&amp;SrcApp=literatum&amp;DestLinkType=FullRecord&amp;KeyUT=A1976BZ10800002">ISI</a></div><div><a href="https://scholar.google.com/scholar_lookup?title=The+resistance+factor+to+Plasmodium+vivax+in+blacks.+The+Duffy-blood-group+genotype%2C+FyFy&amp;author=LH+Miller&amp;author=SJ+Mason&amp;author=DF+Clyde&amp;author=MH+McGinniss&amp;publication_year=1976&amp;pages=302-304&amp;doi=10.1056%2FNEJM197608052950602&amp;pmid=778616">Google Scholar</a></div></div></div></div></div><div class="labeled" role="doc-biblioentry"><div class="label">24.</div><div id="B24" class="citations"><div class="citation"><div class="citation-content">Miller LH, Mason SJ, Dvorak JA, McGinniss MH, and Rothman IK. 1975. Erythrocyte receptors for (Plasmodium knowlesi) malaria: Duffy blood group determinants. <em>Science</em> 189:561â563.</div><div class="external-links"><div><a href="https://doi.org/10.1126/science.1145213">Crossref</a></div><div><a href="https://www.ncbi.nlm.nih.gov/pubmed/1145213">PubMed</a></div><div><a href="http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&amp;DestApp=WOS_CPL&amp;UsrCustomerID=5e3815c904498985e796fc91436abd9a&amp;SrcAuth=atyponcel&amp;SrcApp=literatum&amp;DestLinkType=FullRecord&amp;KeyUT=A1975AL11100026">ISI</a></div><div><a href="https://scholar.google.com/scholar_lookup?title=Erythrocyte+receptors+for+%28Plasmodium+knowlesi%29+malaria%3A+Duffy+blood+group+determinants&amp;author=LH+Miller&amp;author=SJ+Mason&amp;author=JA+Dvorak&amp;author=MH+McGinniss&amp;author=IK+Rothman&amp;publication_year=1975&amp;pages=561-563&amp;doi=10.1126%2Fscience.1145213&amp;pmid=1145213">Google Scholar</a></div></div></div></div></div><div class="labeled" role="doc-biblioentry"><div class="label">25.</div><div id="B25" class="citations"><div class="citation"><div class="citation-content">Ntumngia FB and Adams JH. 2012. Design and immunogenicity of a novel synthetic antigen based on the ligand domain of the <span class="named-content" data-type="genus-species">Plasmodium vivax</span> Duffy binding protein. <em>Clin. Vaccine Immunol.</em> 19:30â36.</div><div class="external-links"><div><a href="https://doi.org/10.1128/CVI.05466-11">Crossref</a></div><div><a href="https://www.ncbi.nlm.nih.gov/pubmed/22116684">PubMed</a></div><div><a href="http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&amp;DestApp=WOS_CPL&amp;UsrCustomerID=5e3815c904498985e796fc91436abd9a&amp;SrcAuth=atyponcel&amp;SrcApp=literatum&amp;DestLinkType=FullRecord&amp;KeyUT=000298675000006">ISI</a></div><div><a href="https://scholar.google.com/scholar_lookup?title=Design+and+immunogenicity+of+a+novel+synthetic+antigen+based+on+the+ligand+domain+of+the+Plasmodium+vivax+Duffy+binding+protein&amp;author=FB+Ntumngia&amp;author=JH+Adams&amp;publication_year=2012&amp;pages=30-36&amp;doi=10.1128%2FCVI.05466-11&amp;pmid=22116684">Google Scholar</a></div></div></div></div></div><div class="labeled" role="doc-biblioentry"><div class="label">26.</div><div id="B26" class="citations"><div class="citation"><div class="citation-content">Ntumngia FB et al. 2012. Conserved and variant epitopes of <span class="named-content" data-type="genus-species">Plasmodium vivax</span> Duffy binding protein as targets of inhibitory monoclonal antibodies. <em>Infect. Immun.</em> 80:1203â1208.</div><div class="external-links"><div><a href="https://doi.org/10.1128/IAI.05924-11">Crossref</a></div><div><a href="https://www.ncbi.nlm.nih.gov/pubmed/22215740">PubMed</a></div><div><a href="https://scholar.google.com/scholar_lookup?title=Conserved+and+variant+epitopes+of+Plasmodium+vivax+Duffy+binding+protein+as+targets+of+inhibitory+monoclonal+antibodies&amp;author=FB+Ntumngia&amp;publication_year=2012&amp;pages=1203-1208&amp;doi=10.1128%2FIAI.05924-11&amp;pmid=22215740">Google Scholar</a></div></div></div></div></div><div class="labeled" role="doc-biblioentry"><div class="label">27.</div><div id="B27" class="citations"><div class="citation"><div class="citation-content">Ouattara A et al. 2010. Lack of allele-specific efficacy of a bivalent AMA1 malaria vaccine. <em>Malar J.</em> 9:175. doi:</div><div class="external-links"><div><a href="https://doi.org/10.1186/1475-2875-9-175">Crossref</a></div><div><a href="https://www.ncbi.nlm.nih.gov/pubmed/20565971">PubMed</a></div><div><a href="http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&amp;DestApp=WOS_CPL&amp;UsrCustomerID=5e3815c904498985e796fc91436abd9a&amp;SrcAuth=atyponcel&amp;SrcApp=literatum&amp;DestLinkType=FullRecord&amp;KeyUT=000280170200001">ISI</a></div><div><a href="https://scholar.google.com/scholar_lookup?title=Lack+of+allele-specific+efficacy+of+a+bivalent+AMA1+malaria+vaccine&amp;author=A+Ouattara&amp;publication_year=2010&amp;pages=175&amp;doi=10.1186%2F1475-2875-9-175&amp;pmid=20565971">Google Scholar</a></div></div></div></div></div><div class="labeled" role="doc-biblioentry"><div class="label">28.</div><div id="B28" class="citations"><div class="citation"><div class="citation-content">Ranjan A and Chitnis CE. 1999. Mapping regions containing binding residues within functional domains of <span class="named-content" data-type="genus-species">Plasmodium vivax</span> and <span class="named-content" data-type="genus-species">Plasmodium knowlesi</span> erythrocyte-binding proteins. <em>Proc. Natl. Acad. Sci. U. S. A.</em> 96:14067â14072.</div><div class="external-links"><div><a href="https://doi.org/10.1073/pnas.96.24.14067">Crossref</a></div><div><a href="https://www.ncbi.nlm.nih.gov/pubmed/10570199">PubMed</a></div><div><a href="http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&amp;DestApp=WOS_CPL&amp;UsrCustomerID=5e3815c904498985e796fc91436abd9a&amp;SrcAuth=atyponcel&amp;SrcApp=literatum&amp;DestLinkType=FullRecord&amp;KeyUT=000083872900085">ISI</a></div><div><a href="https://scholar.google.com/scholar_lookup?title=Mapping+regions+containing+binding+residues+within+functional+domains+of+Plasmodium+vivax+and+Plasmodium+knowlesi+erythrocyte-binding+proteins&amp;author=A+Ranjan&amp;author=CE+Chitnis&amp;publication_year=1999&amp;pages=14067-14072&amp;doi=10.1073%2Fpnas.96.24.14067&amp;pmid=10570199">Google Scholar</a></div></div></div></div></div><div class="labeled" role="doc-biblioentry"><div class="label">29.</div><div id="B29" class="citations"><div class="citation"><div class="citation-content">Russell B et al. 2011. A reliable ex vivo invasion assay of human reticulocytes by Plasmodium vivax. <em>Blood</em> 118:e74âe81. doi:</div><div class="external-links"><div><a href="https://doi.org/10.1182/blood-2011-04-348748">Crossref</a></div><div><a href="https://www.ncbi.nlm.nih.gov/pubmed/21768300">PubMed</a></div><div><a href="http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&amp;DestApp=WOS_CPL&amp;UsrCustomerID=5e3815c904498985e796fc91436abd9a&amp;SrcAuth=atyponcel&amp;SrcApp=literatum&amp;DestLinkType=FullRecord&amp;KeyUT=000295359300002">ISI</a></div><div><a href="https://scholar.google.com/scholar_lookup?title=A+reliable+ex+vivo+invasion+assay+of+human+reticulocytes+by+Plasmodium+vivax&amp;author=B+Russell&amp;publication_year=2011&amp;pages=e74-e81&amp;doi=10.1182%2Fblood-2011-04-348748&amp;pmid=21768300">Google Scholar</a></div></div></div></div></div><div class="labeled" role="doc-biblioentry"><div class="label">30.</div><div id="B30" class="citations"><div class="citation"><div class="citation-content">Singh AP, Puri SK, and Chitnis CE. 2002. Antibodies raised against receptor-binding domain of Plasmodium knowlesi Duffy binding protein inhibit erythrocyte invasion. <em>Mol. Biochem. Parasitol.</em> 121:21â31.</div><div class="external-links"><div><a href="https://doi.org/10.1016/S0166-6851(02)00017-8">Crossref</a></div><div><a href="https://www.ncbi.nlm.nih.gov/pubmed/11985860">PubMed</a></div><div><a href="https://scholar.google.com/scholar_lookup?title=Antibodies+raised+against+receptor-binding+domain+of+Plasmodium+knowlesi+Duffy+binding+protein+inhibit+erythrocyte+invasion&amp;author=AP+Singh&amp;author=SK+Puri&amp;author=CE+Chitnis&amp;publication_year=2002&amp;pages=21-31&amp;doi=10.1016%2FS0166-6851%2802%2900017-8&amp;pmid=11985860">Google Scholar</a></div></div></div></div></div><div class="labeled" role="doc-biblioentry"><div class="label">31.</div><div id="B31" class="citations"><div class="citation"><div class="citation-content">Singh K et al. 2010. Subdomain 3 of Plasmodium falciparum VAR2CSA DBL3x is identified as a minimal chondroitin sulfate A-binding region. <em>J. Biol. Chem.</em> 285:24855â24862.</div><div class="external-links"><div><a href="https://doi.org/10.1074/jbc.M110.118612">Crossref</a></div><div><a href="https://www.ncbi.nlm.nih.gov/pubmed/20529864">PubMed</a></div><div><a href="http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&amp;DestApp=WOS_CPL&amp;UsrCustomerID=5e3815c904498985e796fc91436abd9a&amp;SrcAuth=atyponcel&amp;SrcApp=literatum&amp;DestLinkType=FullRecord&amp;KeyUT=000280542100058">ISI</a></div><div><a href="https://scholar.google.com/scholar_lookup?title=Subdomain+3+of+Plasmodium+falciparum+VAR2CSA+DBL3x+is+identified+as+a+minimal+chondroitin+sulfate+A-binding+region&amp;author=K+Singh&amp;publication_year=2010&amp;pages=24855-24862&amp;doi=10.1074%2Fjbc.M110.118612&amp;pmid=20529864">Google Scholar</a></div></div></div></div></div><div class="labeled" role="doc-biblioentry"><div class="label">32.</div><div id="B32" class="citations"><div class="citation"><div class="citation-content">Singh K et al. 2008. Structure of the DBL3x domain of pregnancy-associated malaria protein VAR2CSA complexed with chondroitin sulfate A. <em>Nat. Struct. Mol. Biol.</em> 15:932â938.</div><div class="external-links"><div><a href="https://doi.org/10.1038/nsmb.1479">Crossref</a></div><div><a href="https://www.ncbi.nlm.nih.gov/pubmed/19172746">PubMed</a></div><div><a href="http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&amp;DestApp=WOS_CPL&amp;UsrCustomerID=5e3815c904498985e796fc91436abd9a&amp;SrcAuth=atyponcel&amp;SrcApp=literatum&amp;DestLinkType=FullRecord&amp;KeyUT=000258928400012">ISI</a></div><div><a href="https://scholar.google.com/scholar_lookup?title=Structure+of+the+DBL3x+domain+of+pregnancy-associated+malaria+protein+VAR2CSA+complexed+with+chondroitin+sulfate+A&amp;author=K+Singh&amp;publication_year=2008&amp;pages=932-938&amp;doi=10.1038%2Fnsmb.1479&amp;pmid=19172746">Google Scholar</a></div></div></div></div></div><div class="labeled" role="doc-biblioentry"><div class="label">33.</div><div id="B33" class="citations"><div class="citation"><div class="citation-content">Singh S et al. 2001. Biochemical, biophysical, and functional characterization of bacterially expressed and refolded receptor binding domain of Plasmodium vivax Duffy-binding protein. <em>J. Biol. Chem.</em> 276:17111â17116.</div><div class="external-links"><div><a href="https://doi.org/10.1074/jbc.M101531200">Crossref</a></div><div><a href="https://www.ncbi.nlm.nih.gov/pubmed/11279211">PubMed</a></div><div><a href="http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&amp;DestApp=WOS_CPL&amp;UsrCustomerID=5e3815c904498985e796fc91436abd9a&amp;SrcAuth=atyponcel&amp;SrcApp=literatum&amp;DestLinkType=FullRecord&amp;KeyUT=000168730400069">ISI</a></div><div><a href="https://scholar.google.com/scholar_lookup?title=Biochemical%2C+biophysical%2C+and+functional+characterization+of+bacterially+expressed+and+refolded+receptor+binding+domain+of+Plasmodium+vivax+Duffy-binding+protein&amp;author=S+Singh&amp;publication_year=2001&amp;pages=17111-17116&amp;doi=10.1074%2Fjbc.M101531200&amp;pmid=11279211">Google Scholar</a></div></div></div></div></div><div class="labeled" role="doc-biblioentry"><div class="label">34.</div><div id="B34" class="citations"><div class="citation"><div class="citation-content">Singh SK, Hora R, Belrhali H, Chitnis CE, and Sharma A. 2006. Structural basis for Duffy recognition by the malaria parasite Duffy-binding-like domain. <em>Nature</em> 439:741â744.</div><div class="external-links"><div><a href="https://doi.org/10.1038/nature04443">Crossref</a></div><div><a href="https://www.ncbi.nlm.nih.gov/pubmed/16372020">PubMed</a></div><div><a href="http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&amp;DestApp=WOS_CPL&amp;UsrCustomerID=5e3815c904498985e796fc91436abd9a&amp;SrcAuth=atyponcel&amp;SrcApp=literatum&amp;DestLinkType=FullRecord&amp;KeyUT=000235193100048">ISI</a></div><div><a href="https://scholar.google.com/scholar_lookup?title=Structural+basis+for+Duffy+recognition+by+the+malaria+parasite+Duffy-binding-like+domain&amp;author=SK+Singh&amp;author=R+Hora&amp;author=H+Belrhali&amp;author=CE+Chitnis&amp;author=A+Sharma&amp;publication_year=2006&amp;pages=741-744&amp;doi=10.1038%2Fnature04443&amp;pmid=16372020">Google Scholar</a></div></div></div></div></div><div class="labeled" role="doc-biblioentry"><div class="label">35.</div><div id="B35" class="citations"><div class="citation"><div class="citation-content">Tran TM et al. 2005. Detection of a Plasmodium vivax erythrocyte binding protein by flow cytometry. <em>Cytometry A</em> 63:59â66.</div><div class="external-links"><div><a href="https://doi.org/10.1002/cyto.a.20098">Crossref</a></div><div><a href="https://www.ncbi.nlm.nih.gov/pubmed/15584018">PubMed</a></div><div><a href="http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&amp;DestApp=WOS_CPL&amp;UsrCustomerID=5e3815c904498985e796fc91436abd9a&amp;SrcAuth=atyponcel&amp;SrcApp=literatum&amp;DestLinkType=FullRecord&amp;KeyUT=000226824800007">ISI</a></div><div><a href="https://scholar.google.com/scholar_lookup?title=Detection+of+a+Plasmodium+vivax+erythrocyte+binding+protein+by+flow+cytometry&amp;author=TM+Tran&amp;publication_year=2005&amp;pages=59-66&amp;doi=10.1002%2Fcyto.a.20098&amp;pmid=15584018">Google Scholar</a></div></div></div></div></div><div class="labeled" role="doc-biblioentry"><div class="label">36.</div><div id="B36" class="citations"><div class="citation"><div class="citation-content">Tsuboi T et al. 1994. Natural variation within the principal adhesion domain of the <span class="named-content" data-type="genus-species">Plasmodium vivax</span> Duffy binding protein. <em>Infect. Immun.</em> 62:5581â5586.</div><div class="external-links"><div><a href="https://doi.org/10.1128/iai.62.12.5581-5586.1994">Crossref</a></div><div><a href="https://www.ncbi.nlm.nih.gov/pubmed/7960140">PubMed</a></div><div><a href="http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&amp;DestApp=WOS_CPL&amp;UsrCustomerID=5e3815c904498985e796fc91436abd9a&amp;SrcAuth=atyponcel&amp;SrcApp=literatum&amp;DestLinkType=FullRecord&amp;KeyUT=A1994PT32900051">ISI</a></div><div><a href="https://scholar.google.com/scholar_lookup?title=Natural+variation+within+the+principal+adhesion+domain+of+the+Plasmodium+vivax+Duffy+binding+protein&amp;author=T+Tsuboi&amp;publication_year=1994&amp;pages=5581-5586&amp;doi=10.1128%2Fiai.62.12.5581-5586.1994&amp;pmid=7960140">Google Scholar</a></div></div></div></div></div><div class="labeled" role="doc-biblioentry"><div class="label">37.</div><div id="B37" class="citations"><div class="citation"><div class="citation-content">VanBuskirk KM, Sevova E, and Adams JH. 2004. Conserved residues in the Plasmodium vivax Duffy-binding protein ligand domain are critical for erythrocyte receptor recognition. <em>Proc. Natl. Acad. Sci. U. S. A.</em> 101:15754â15759.</div><div class="external-links"><div><a href="https://doi.org/10.1073/pnas.0405421101">Crossref</a></div><div><a href="https://www.ncbi.nlm.nih.gov/pubmed/15498870">PubMed</a></div><div><a href="http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&amp;DestApp=WOS_CPL&amp;UsrCustomerID=5e3815c904498985e796fc91436abd9a&amp;SrcAuth=atyponcel&amp;SrcApp=literatum&amp;DestLinkType=FullRecord&amp;KeyUT=000224922300038">ISI</a></div><div><a href="https://scholar.google.com/scholar_lookup?title=Conserved+residues+in+the+Plasmodium+vivax+Duffy-binding+protein+ligand+domain+are+critical+for+erythrocyte+receptor+recognition&amp;author=KM+VanBuskirk&amp;author=E+Sevova&amp;author=JH+Adams&amp;publication_year=2004&amp;pages=15754-15759&amp;doi=10.1073%2Fpnas.0405421101&amp;pmid=15498870">Google Scholar</a></div></div></div></div></div><div class="labeled" role="doc-biblioentry"><div class="label">38.</div><div id="B38" class="citations"><div class="citation"><div class="citation-content">Walsh C. 2006. Posttranslational modification of proteins: expanding nature's inventory. Roberts and Co. Publishers, Englewood, CO.</div><div class="external-links"><div><a href="https://scholar.google.com/scholar_lookup?title=Posttranslational+modification+of+proteins%3A+expanding+nature%27s+inventory&amp;author=C+Walsh&amp;publication_year=2006">Google Scholar</a></div></div></div></div></div><div class="labeled" role="doc-biblioentry"><div class="label">39.</div><div id="B39" class="citations"><div class="citation"><div class="citation-content">Wertheimer SP and Barnwell JW. 1989. Plasmodium vivax interaction with the human Duffy blood group glycoprotein: identification of a parasite receptor-like protein. <em>Exp. Parasitol.</em> 69:340â350.</div><div class="external-links"><div><a href="https://doi.org/10.1016/0014-4894(89)90083-0">Crossref</a></div><div><a href="https://www.ncbi.nlm.nih.gov/pubmed/2680568">PubMed</a></div><div><a href="http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&amp;DestApp=WOS_CPL&amp;UsrCustomerID=5e3815c904498985e796fc91436abd9a&amp;SrcAuth=atyponcel&amp;SrcApp=literatum&amp;DestLinkType=FullRecord&amp;KeyUT=A1989AX63900004">ISI</a></div><div><a href="https://scholar.google.com/scholar_lookup?title=Plasmodium+vivax+interaction+with+the+human+Duffy+blood+group+glycoprotein%3A+identification+of+a+parasite+receptor-like+protein&amp;author=SP+Wertheimer&amp;author=JW+Barnwell&amp;publication_year=1989&amp;pages=340-350&amp;doi=10.1016%2F0014-4894%2889%2990083-0&amp;pmid=2680568">Google Scholar</a></div></div></div></div></div><div class="labeled" role="doc-biblioentry"><div class="label">40.</div><div id="B40" class="citations"><div class="citation"><div class="citation-content">Xainli J, Adams JH, and King CL. 2000. The erythrocyte binding motif of Plasmodium vivax Duffy binding protein is highly polymorphic and functionally conserved in isolates from Papua New Guinea. <em>Mol. Biochem. Parasitol.</em> 111:253â260.</div><div class="external-links"><div><a href="https://doi.org/10.1016/S0166-6851(00)00315-7">Crossref</a></div><div><a href="https://www.ncbi.nlm.nih.gov/pubmed/11163434">PubMed</a></div><div><a href="http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&amp;DestApp=WOS_CPL&amp;UsrCustomerID=5e3815c904498985e796fc91436abd9a&amp;SrcAuth=atyponcel&amp;SrcApp=literatum&amp;DestLinkType=FullRecord&amp;KeyUT=000166121900002">ISI</a></div><div><a href="https://scholar.google.com/scholar_lookup?title=The+erythrocyte+binding+motif+of+Plasmodium+vivax+Duffy+binding+protein+is+highly+polymorphic+and+functionally+conserved+in+isolates+from+Papua+New+Guinea&amp;author=J+Xainli&amp;author=JH+Adams&amp;author=CL+King&amp;publication_year=2000&amp;pages=253-260&amp;doi=10.1016%2FS0166-6851%2800%2900315-7&amp;pmid=11163434">Google Scholar</a></div></div></div></div></div><div class="labeled" role="doc-biblioentry"><div class="label">41.</div><div id="B41" class="citations"><div class="citation"><div class="citation-content">Xainli J et al. 2002. Age-dependent cellular immune responses to Plasmodium vivax Duffy binding protein in humans. <em>J. Immunol.</em> 169:3200â3207.</div><div class="external-links"><div><a href="https://doi.org/10.4049/jimmunol.169.6.3200">Crossref</a></div><div><a href="https://www.ncbi.nlm.nih.gov/pubmed/12218138">PubMed</a></div><div><a href="https://scholar.google.com/scholar_lookup?title=Age-dependent+cellular+immune+responses+to+Plasmodium+vivax+Duffy+binding+protein+in+humans&amp;author=J+Xainli&amp;publication_year=2002&amp;pages=3200-3207&amp;doi=10.4049%2Fjimmunol.169.6.3200&amp;pmid=12218138">Google Scholar</a></div></div></div></div></div></section></div></section><div class="core-collateral"><div id="core-collateral-info" role="tabpanel"><header><h2><i class="icon-info" aria-hidden="true"></i>Information &amp; Contributors</h2></header><section id="tab-information" aria-labelledby="information" role="tabpanel"><h3>Information</h3><section class="core-self-citation"><h4>Published In</h4><div class="core-journal-presentation">



        
        <div class="cover-image"><div class="cover-image__image"><img src="/cms/asset/4be65bbe-8f41-4bf8-96a0-be5b51aae56f/iai.2012.80.issue-8.cover.gif" alt="Infection and Immunity cover image"/></div></div>
<div class="core-journal-description"><div property="isPartOf" typeof="Periodical"><span property="name">Infection and Immunity</span></div><div class="core-enumeration"><span property="isPartOf" typeof="PublicationVolume">Volume <span property="volumeNumber">80</span></span> â¢ <span property="isPartOf" typeof="PublicationIssue">Number <span property="issueNumber">8</span></span> â¢ <span property="datePublished">August 2012</span></div><div class="core-pagination"><span class="heading">Pages</span>: <span class="content"><span property="pageStart">2920</span> - <span property="pageEnd">2928</span></span></div><div class="core-editors"><span class="heading">Editor</span>: <span role="list"><span role="listitem" property="editor" typeof="Person"><span property="givenName">J. F.</span> <span property="familyName">Urban</span> Jr.</span></span></div><div class="core-pmid"><span class="heading">PubMed</span>: <a class="content" href="https://pubmed.ncbi.nlm.nih.gov/22615246/" property="sameAs">22615246</a></div></div></div></section><section class="core-copyright"><h4>Copyright</h4><div role="paragraph">Â© 2012 American Society for Microbiology.</div></section><section class="core-history"><h4>History</h4><div>Received: 25 February 2012</div><div>Returned for modification: 22 March 2012</div><div>Accepted: 11 May 2012</div><div>Published online: 18 July 2012</div></section><section class="core-permissions"><h4>Permissions</h4><div>Request permissions for this article.</div><div><a href="https://marketplace.copyright.com/rs-ui-web/mp/search/all/10.1128%2FIAI.00206-12">Request Permissions</a></div></section><div class="core-download"><a href="/doi/pdf/10.1128/IAI.00206-12?download=true" class="btn btn-primary"><i aria-hidden="true" class="icon-PDF"></i><span>Download PDF</span></a></div></section><section id="tab-contributors" aria-labelledby="contributors" role="tabpanel"><h3>Contributors</h3><section class="core-authors"><h4>Authors</h4><div id="con1" property="author" typeof="Person"><div class="heading"><span property="givenName">Asim A.</span> <span property="familyName">Siddiqui</span></div><div class="content"><div class="affiliations"><div property="affiliation" typeof="Organization"><span property="name">Case Western Reserve University, Center for Global Health and Diseases, Cleveland, Ohio, USA</span></div></div><div class="core-author-link"><a href="/authored-by/Siddiqui/Asim+A">View all articles by this author</a></div></div></div><div id="con2" property="author" typeof="Person"><div class="heading"><span property="givenName">Jia</span> <span property="familyName">Xainli</span></div><div class="content"><div class="affiliations"><div property="affiliation" typeof="Organization"><span property="name">Case Western Reserve University, Center for Global Health and Diseases, Cleveland, Ohio, USA</span></div></div><div class="core-author-link"><a href="/authored-by/Xainli/Jia">View all articles by this author</a></div></div></div><div id="con3" property="author" typeof="Person"><div class="heading"><span property="givenName">Jesse</span> <span property="familyName">Schloegel</span></div><div class="content"><div class="affiliations"><div property="affiliation" typeof="Organization"><span property="name">Department of Global Health, University of South Florida, Tampa, Florida, USA</span></div></div><div class="core-author-link"><a href="/authored-by/Schloegel/Jesse">View all articles by this author</a></div></div></div><div id="con4" property="author" typeof="Person"><div class="heading"><span property="givenName">Lenore</span> <span property="familyName">Carias</span></div><div class="content"><div class="affiliations"><div property="affiliation" typeof="Organization"><span property="name">Case Western Reserve University, Center for Global Health and Diseases, Cleveland, Ohio, USA</span></div></div><div class="core-author-link"><a href="/authored-by/Carias/Lenore">View all articles by this author</a></div></div></div><div id="con5" property="author" typeof="Person"><div class="heading"><span property="givenName">Francis</span> <span property="familyName">Ntumngia</span></div><div class="content"><div class="affiliations"><div property="affiliation" typeof="Organization"><span property="name">Department of Global Health, University of South Florida, Tampa, Florida, USA</span></div></div><div class="core-author-link"><a href="/authored-by/Ntumngia/Francis">View all articles by this author</a></div></div></div><div id="con6" property="author" typeof="Person"><div class="heading"><span property="givenName">Menachem</span> <span property="familyName">Shoham</span></div><div class="content"><div class="affiliations"><div property="affiliation" typeof="Organization"><span property="name">Department of Biochemistry, Case Western Reserve University, Cleveland, Ohio, USA</span></div></div><div class="core-author-link"><a href="/authored-by/Shoham/Menachem">View all articles by this author</a></div></div></div><div id="con7" property="author" typeof="Person"><div class="heading"><span property="givenName">Joanne L.</span> <span property="familyName">Casey</span></div><div class="content"><div class="affiliations"><div property="affiliation" typeof="Organization"><span property="name">Department of Biochemistry, La Trobe University, Victoria, Australia</span></div></div><div class="core-author-link"><a href="/authored-by/Casey/Joanne+L">View all articles by this author</a></div></div></div><div id="con8" property="author" typeof="Person"><div class="heading"><span property="givenName">Michael</span> <span property="familyName">Foley</span></div><div class="content"><div class="affiliations"><div property="affiliation" typeof="Organization"><span property="name">Department of Biochemistry, La Trobe University, Victoria, Australia</span></div></div><div class="core-author-link"><a href="/authored-by/Foley/Michael">View all articles by this author</a></div></div></div><div id="con9" property="author" typeof="Person"><div class="heading"><span property="givenName">John H.</span> <span property="familyName">Adams</span></div><div class="content"><div class="affiliations"><div property="affiliation" typeof="Organization"><span property="name">Department of Global Health, University of South Florida, Tampa, Florida, USA</span></div></div><div class="core-author-link"><a href="/authored-by/Adams/John+H">View all articles by this author</a></div></div></div><div id="con10" property="author" typeof="Person"><div class="heading"><span property="givenName">Christopher L.</span> <span property="familyName">King</span></div><div class="content"><div class="affiliations"><div property="affiliation" typeof="Organization"><span property="name">Case Western Reserve University, Center for Global Health and Diseases, Cleveland, Ohio, USA</span></div><div property="affiliation" typeof="Organization"><span property="name">Veterans Affairs Research Service, Louis B. Stokes VA Medical Center, Cleveland, Ohio, USA</span></div></div><div class="core-author-link"><a href="/authored-by/King/Christopher+L">View all articles by this author</a></div></div></div></section><section class="core-editors"><h4>Editor</h4><div id="editor" property="editor" typeof="Person"><div class="heading"><span property="givenName">J. F.</span> <span property="familyName">Urban</span> Jr.</div><div class="content"><div property="jobTitle">Editor</div></div></div></section><section class="core-authors-notes"><h4>Notes</h4><div role="doc-footnote">Address correspondence to Christopher L. King, <a href="/cdn-cgi/l/email-protection#84e7fcefb6b5c4e7e5f7e1aae1e0f1"><span class="__cf_email__" data-cfemail="73100b18414233101200165d161706">[email&#160;protected]</span></a>.</div><div role="doc-footnote">A.A.S., J.X., and J.S. contributed equally to this study.</div></section></section></div><div id="core-collateral-metrics" role="tabpanel"><header><h2><i class="icon-timeline" aria-hidden="true"></i>Metrics &amp; Citations</h2></header><section id="tab-metrics-inner" aria-labelledby="metrics-inner" role="tabpanel"><h3>Metrics</h3><section>



        
        







                <div class="sidebar-metric-container">
                        <input class="sidebar-metric__data" type="hidden" name="json" value='{"data":{"dataSections":[{"total":"200","months":[{"month":"2022-2-1","count":19},{"month":"2022-1-1","count":17},{"month":"2021-12-1","count":16},{"month":"2021-11-1","count":27},{"month":"2021-10-1","count":35},{"month":"2021-9-1","count":15},{"month":"2021-8-1","count":33},{"month":"2021-7-1","count":25},{"month":"2021-6-1","count":13}],"color":"color-4","firstMonth":[],"id":"download","title":"Download","startDate":"2021-6-1","displayDefault":true},{"total":"12","months":[{"month":"2022-2-1","count":0},{"month":"2022-1-1","count":0},{"month":"2021-12-1","count":0},{"month":"2021-11-1","count":0},{"month":"2021-10-1","count":0},{"month":"2021-9-1","count":0},{"month":"2021-8-1","count":0},{"month":"2021-7-1","count":0},{"month":"2021-6-1","count":0},{"month":"2021-5-1","count":0},{"month":"2021-4-1","count":0},{"month":"2021-3-1","count":0},{"month":"2021-2-1","count":0},{"month":"2021-1-1","count":0},{"month":"2020-12-1","count":0},{"month":"2020-11-1","count":0},{"month":"2020-10-1","count":0},{"month":"2020-9-1","count":0},{"month":"2020-8-1","count":0},{"month":"2020-7-1","count":0},{"month":"2020-6-1","count":0},{"month":"2020-5-1","count":0},{"month":"2020-4-1","count":0},{"month":"2020-3-1","count":0},{"month":"2020-2-1","count":0},{"month":"2020-1-1","count":0},{"month":"2019-12-1","count":0},{"month":"2019-11-1","count":0},{"month":"2019-10-1","count":0},{"month":"2019-9-1","count":0},{"month":"2019-8-1","count":0},{"month":"2019-7-1","count":0},{"month":"2019-6-1","count":0},{"month":"2019-5-1","count":0},{"month":"2019-4-1","count":0},{"month":"2019-3-1","count":0},{"month":"2019-2-1","count":0},{"month":"2019-1-1","count":0},{"month":"2018-12-1","count":0},{"month":"2018-11-1","count":0},{"month":"2018-10-1","count":0},{"month":"2018-9-1","count":0},{"month":"2018-8-1","count":0},{"month":"2018-7-1","count":0},{"month":"2018-6-1","count":0},{"month":"2018-5-1","count":0},{"month":"2018-4-1","count":0},{"month":"2018-3-1","count":0},{"month":"2018-2-1","count":0},{"month":"2018-1-1","count":0},{"month":"2017-12-1","count":0},{"month":"2017-11-1","count":0},{"month":"2017-10-1","count":0},{"month":"2017-9-1","count":0},{"month":"2017-8-1","count":0},{"month":"2017-7-1","count":0},{"month":"2017-6-1","count":0},{"month":"2017-5-1","count":0},{"month":"2017-4-1","count":0},{"month":"2017-3-1","count":0},{"month":"2017-2-1","count":0},{"month":"2017-1-1","count":0},{"month":"2016-12-1","count":1},{"month":"2016-11-1","count":0},{"month":"2016-10-1","count":0},{"month":"2016-9-1","count":0},{"month":"2016-8-1","count":0},{"month":"2016-7-1","count":0},{"month":"2016-6-1","count":1},{"month":"2016-5-1","count":0},{"month":"2016-4-1","count":0},{"month":"2016-3-1","count":0},{"month":"2016-2-1","count":1},{"month":"2016-1-1","count":0},{"month":"2015-12-1","count":0},{"month":"2015-11-1","count":0},{"month":"2015-10-1","count":0},{"month":"2015-9-1","count":0},{"month":"2015-8-1","count":0},{"month":"2015-7-1","count":0},{"month":"2015-6-1","count":0},{"month":"2015-5-1","count":0},{"month":"2015-4-1","count":0},{"month":"2015-3-1","count":1},{"month":"2015-2-1","count":1},{"month":"2015-1-1","count":0},{"month":"2014-12-1","count":0},{"month":"2014-11-1","count":0},{"month":"2014-10-1","count":0},{"month":"2014-9-1","count":0},{"month":"2014-8-1","count":2},{"month":"2014-7-1","count":0},{"month":"2014-6-1","count":0},{"month":"2014-5-1","count":0},{"month":"2014-4-1","count":1},{"month":"2014-3-1","count":0},{"month":"2014-2-1","count":0},{"month":"2014-1-1","count":1},{"month":"2013-12-1","count":0},{"month":"2013-11-1","count":0},{"month":"2013-10-1","count":0},{"month":"2013-9-1","count":0},{"month":"2013-8-1","count":0},{"month":"2013-7-1","count":0},{"month":"2013-6-1","count":1},{"month":"2013-5-1","count":0},{"month":"2013-4-1","count":0},{"month":"2013-3-1","count":0},{"month":"2013-2-1","count":0},{"month":"2013-1-1","count":0},{"month":"2012-12-1","count":1},{"month":"2012-11-1","count":1}],"color":"color-0","id":"citation","title":"Citation","startDate":"2012-11-1","displayDefault":true}],"doi":"10.1128/IAI.00206-12","widgetTitle":"Article Metrics"}}'>
                </div>
        
</section><section></section><section class="text-right"><a href="/doi/metrics/10.1128/IAI.00206-12" class="btn btn--inverse open-in-viewer"><span>VIEW ALL METRICS</span><i class="icon-open_in_new"></i></a></section></section><section id="tab-citations" aria-labelledby="citations" role="tabpanel"><h3>Citations</h3><section></section><section>



        
        <div class="citation-download">
	<p class="citation-msg">
		If you have the appropriate software installed, you can download article citation data to the citation manager of your choice. Simply select your manager software from the list below and click Download.
	</p>
	<!-- download options -->
	<form action="/action/downloadCitation" name="frmCitmgr" class="citation-form" method="post" target="_self"><input type="hidden" name="doi" value="10.1128/IAI.00206-12"><input type="hidden" name="downloadFileName" value="csp_80_"><input type="hidden" name="include" value="abs">
		<fieldset class="format-select">
			<label for="slct_format">Format</label>
			<div class="select-container">
				<select id="slct_format" name="format" class="js__slcInclude">
					<option value="" selected="selected">Please select one from the list</option>
					<option value="ris">RIS (ProCite, Reference Manager)</option>
					<option value="endnote">EndNote</option>
					<option value="bibtex">BibTex</option>
					<option value="medlars">Medlars</option>
					<option value="refworks">RefWorks</option>
				</select>
			</div>
			<label class="label-direct" for="direct">
				<input id="direct" type="checkbox" name="direct" value="" checked="checked">
				<span class="round-check"><span class="check"></span></span>
				Direct import
			</label>
		</fieldset>           
		<footer class="form-footer">
			<input onclick="onCitMgrSubmit()" class="formbutton" type="submit" name="submit" value="Download">
		</footer>
	</form>
</div>

</section></section></div><div id="core-collateral-fulltext-options" role="tabpanel"><header><h2><i class="icon-eye" aria-hidden="true"></i>View Options</h2></header><div tabindex="0" class="section--wrapper"><h3>View options</h3><section><h4>ePub</h4><a href="https://journals.asm.org/doi/epub/10.1128/IAI.00206-12" class="btn"><i aria-hidden="true" class="icon-epub"></i><span>Open ePub</span></a></section><section><h4>PDF</h4><a href="/doi/pdf/10.1128/IAI.00206-12?download=true" download="true" class="btn btn--pdf"><i aria-hidden="true" class="icon-PDF"></i><span>Download PDF</span></a></section><section><h4>Full Text</h4><a href="https://journals.asm.org/doi/full/10.1128/IAI.00206-12" class="btn"><i aria-hidden="true" class="icon-subject"></i><span>Open Full Text</span></a></section></div><!-- Its needed to duplicate this for PB check Pill.js as well--><div tabindex="-1" class="section--wrapper"><h3>Get Access</h3><section>



        
        












    <div class="purchaseArea pill__item" id="purchaseArea">
        <div class="login-options" data-pb-dropzone="login-options">
            
        </div>
        <div class="purchaseOptions">
            <div class="purchaseOptions--header">
                <h4 class="purchaseArea--section-heading">
                    PURCHASE OPTIONS
                </h4>
                
                        <div class="save-for-later">
                            <a data-bind="saveItem" data-doi="10.1128/IAI.00206-12" class="purchaseOptions--save" href="/action/saveItem?doi=10.1128/IAI.00206-12">
                                <i aria-hidden="true" class="icon-heart mx-1"></i>
                                <span>Save for later</span>
                            </a>
                            <a class="saved-go-cart hidden"  href="/action/showCart?FlowID=2"><span class="icon-cart-icon-material"></span> Item saved, go to cart </a>
                        </div>
                    
            </div>
            <p class="purchaseArea--section-info">
                Subscribe and get full access to this article
            </p>

            <div class="purchaseOptions--options-list">
                











<div class="purchase-options-container">
    

   
        <div class="savedItem-info hidden">
            <p></p>
        </div>
    

     
            
                
                
                        <div class="purchaseMessage hidden" data-item="ASMJ_PPV-ELECTRONIC-USD-10.1128/IAI.00206-12-500044">
                            <p class="errorMsgBox"></p>
                        </div>
                        <div class="add-journal-to-cart">
                            <div class="purchaseOptions--option mb-3">
                                 
                                    <h5 class="option-title">Buy Article</h5>
                                    <span class="option-info mb-1">Infection and Immunity</span>
                                    <span class="option-info">Vol.80 &bull; Issue 8 &bull; 
                                            ASM Journals Pay Per View, PPV 25
                                        </span>
                                    <div class="option-actions mt-3 pt-3">
                                        <div class="option-price">
                                            <b>$25.00</b>
                                        </div>
                                        <a href="/action/addToCart?id=ASMJ_PPV-ELECTRONIC-USD-10.1128/IAI.00206-12-500044" data-bind="addItem"
                                           data-key="ASMJ_PPV-ELECTRONIC-USD-10.1128/IAI.00206-12-500044" data-entity="ASMJ_PPV-ELECTRONIC-USD-10.1128/IAI.00206-12-500044"
                                           class="btn btn-primary btn--borderless">
                                            <i aria-hidden="true" class="mx-2 icon-shopping_cart"> </i>
                                            <span>ADD TO CART</span>
                                        </a>
                                    </div>
                                 
                            <div class="option-actions mt-3 pt-3 hidden" data-item="ASMJ_PPV-ELECTRONIC-USD-10.1128/IAI.00206-12-500044" style="justify-content: flex-end">
                                <a href="/action/showCart?FlowID=2" class="btn btn-primary btn--borderless">
                                    <span>Checkout</span>
                                </a>
                            </div>
                        </div>

                        <div class="purchaseOptions--option mb-3">
                                                             <h5 class="option-title">Buy Article</h5>
                                <span class="option-info mb-1">Infection and Immunity</span>
                                <span class="option-info">Vol.80 &bull; Issue 8 &bull; 
                                        ASM Journals Pay Per View, PPV 25
                                    
                                </span>
                             
                             <div class="option-actions mt-3 pt-3 hidden"
                                     data-item="ASMJ_PPV-ELECTRONIC-USD-10.1128/IAI.00206-12-500044" style="justify-content: flex-end">
                                    <a href="/action/showCart?FlowID=2" class="btn btn-primary btn--borderless">
                                        <span>Checkout</span>
                                    </a>
                             </div>
                        </div>
                        </div>
                    
            
        

    
</div>

                <div class="purchaseOptions--option">
                    <h5 class="option-title">Journal Subscription</h5>
                    <span class="option-info mb-1">Infection and Immunity</span>
                    <div class="option-actions mt-3 pt-3">
                        <div class="option-actions--info">ASM members can purchase subscriptions to journals.</div>
                        <a href="/action/ssostart?idp=https%3A%2F%2Flogin.asm.org%2Fidp%2Fshibboleth&amp;redirectUri=%2Fdoi%2F10.1128%2FIAI.00206-12" redirectUri="/doi/10.1128/IAI.00206-12" class="btn btn-primary btn--borderless">
                            
                            <span>Join or renew</span>
                            <i aria-hidden="true" class="mx-2 icon-open_in_new"></i>
                        </a>
                    </div>
                </div>
            </div>
        </div>
    </div>




</section></div></div><div id="core-collateral-media" role="tabpanel"><header><h2><i class="icon-photo" aria-hidden="true"></i>Figures and Media</h2></header><section id="tab-figures" aria-labelledby="figures" role="tabpanel"><h3>Figures</h3></section><section id="tab-other" aria-labelledby="other" role="tabpanel"><h3>Media</h3><section>



        
        
</section></section></div><div id="core-collateral-tables" role="tabpanel"><header><h2><i class="icon-tables" aria-hidden="true"></i>Tables</h2></header></div><div id="core-collateral-share" role="tabpanel"><header><h2><i class="icon-share" aria-hidden="true"></i>Share</h2></header><h3>Share</h3><div class="section--wrapper"><section><h4>Share the article link</h4><div id="share-self"><p><a href="#" target="_blank" class="share-self__source"></a></p><button class="btn btn--inverse share-self__action"><i aria-hidden="true" class="icon-copy-o"></i><span>Copy Link</span></button><div class="share-self__status"><p class="share-self__success"><i aria-hidden="true" class="icon-check_circle"></i><span>Copied!</span></p><p class="share-self__failed"><i aria-hidden="true" class="icon-x_btnclose"></i><span>Copying failed.</span></p></div></div></section><section><h4>Share with email</h4><p><a href="#" target="_blank" class="btn btn-primary share-email__source"><i class="icon-copy-o"></i><span>EMAIL A COLLEAGUE</span></a></p></section><section><h4>Share on social media</h4><div class="share-buttons"><a role="link" target="_blank" href="#" class="btn btn--facebook addthis_button_facebook"><i aria-hidden="true" class="icon-facebook-2"></i><span>facebook</span></a><a role="link" target="_blank" href="#" class="btn btn--twitter addthis_button_twitter"><i aria-hidden="true" class="icon-twitter"></i><span>twitter</span></a><a role="link" target="_blank" href="#" class="btn btn--linkedin addthis_button_linkedin"><i aria-hidden="true" class="icon-linkedin"></i><span>linkedin</span></a><a role="link" target="_blank" href="#" class="btn btn--email addthis_button_email"><i aria-hidden="true" class="icon-mail"></i><span>email</span></a></div></section></div></div></div></article><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script id="contribution-meta" type="application/json">{
    "doi": "10.1128/IAI.00206-12",
    "toc": "/toc/iai/80/8",
    "issn": "0019-9567"
}</script><div class="article__side-ad hidden">



        
        <!-- /13678947/asm_box -->
<div class="boombox-wrapper">
	<span class="boombox-label">Advertisement</span>
<div id='div-gpt-ad-1594664702378-0' style='width: 300px; height: 250px;'>
  <script>
    googletag.cmd.push(function() { googletag.display('div-gpt-ad-1594664702378-0'); });
  </script>
</div>
</div>
</div>




        
        <div class="article-footer-element">
    <div class="row">
        <div class="col-12">
            <section aria-label="we recommend" class="we-recommend">
               <div id="trendmd-suggestions"></div>
<script defer src='//js.trendmd.com/trendmd.min.js' data-trendmdconfig='{"journal_id":"35290", "element":"#trendmd-suggestions"}'></script>
            </section>
        </div>
    </div>
</div>










        <div data-widget-def="ux3-layout-widget" data-widget-id="9f4096e6-614d-46c7-a704-f706dfcdc172" class="related-tabs swipe-with-arrows">
        



        
        <div class="article-footer-element">









        <div data-widget-def="UX3Tabs" data-widget-id="3c1dc793-20ba-4336-a3d4-bb86a6fc2c43" class="tab  tab--flex" data-ctrl-res="screen-sm">
        



        
        <div data-ctrl-res="screen-md" class="tab"><ul role="tablist" class="tab__nav rlist"><li role="presentation" class="tab__nav__item  active "><a href="#pane-3c1dc793-20ba-4336-a3d4-bb86a6fc2c4301" aria-controls="pane-3c1dc793-20ba-4336-a3d4-bb86a6fc2c4301" role="tab" data-toggle="tab" id="pane-3c1dc793-20ba-4336-a3d4-bb86a6fc2c4301con" aria-selected="true" class="tab__nav__item__link active"><span>Related Articles</span></a></li><li role="presentation" class="tab__nav__item"><a href="#pane-3c1dc793-20ba-4336-a3d4-bb86a6fc2c4311" aria-controls="pane-3c1dc793-20ba-4336-a3d4-bb86a6fc2c4311" role="tab" data-toggle="tab" id="pane-3c1dc793-20ba-4336-a3d4-bb86a6fc2c4311con" aria-selected="false" class="tab__nav__item__link"><span>Related Articles From ASM</span></a></li></ul><div class="tab__content"><div id="pane-3c1dc793-20ba-4336-a3d4-bb86a6fc2c4301" aria-labelledby="pane-3c1dc793-20ba-4336-a3d4-bb86a6fc2c4301con" role="tabpanel" class="tab__pane active">



        
        <section class="related-articles"><ul class="rlist related-articles__items"><li class="related-articles__item"><a href="/doi/10.1128/IAI.00338-15" class="related-articles__item__title">Retraction for Siddiqui et al., Fine Specificity of Plasmodium vivax Duffy Binding Protein Binding Engagement of the Duffy Antigen on Human Erythrocytes</a><ul class="meta__authors rlist--inline loa mobile-authors" title="list of authors">
   <li><span class="hlFld-ContribAuthor"><a href="/action/doSearch?ContribAuthorRaw=Siddiqui%2C+Asim+A" title="Asim A. Siddiqui">Asim A. Siddiqui</a></span>, </li>
   <li><span class="hlFld-ContribAuthor"><a href="/action/doSearch?ContribAuthorRaw=Xainli%2C+Jia" title="Jia Xainli">Jia Xainli</a></span>, </li>
   <li><span class="hlFld-ContribAuthor"><a href="/action/doSearch?ContribAuthorRaw=Schloegel%2C+Jesse" title="Jesse Schloegel">Jesse Schloegel</a></span>, </li>
   <li><span class="hlFld-ContribAuthor"><a href="/action/doSearch?ContribAuthorRaw=Carias%2C+Lenore" title="Lenore Carias">Lenore Carias</a></span>, </li>
   <li><span class="hlFld-ContribAuthor"><a href="/action/doSearch?ContribAuthorRaw=Ntumngia%2C+Francis" title="Francis Ntumngia">Francis Ntumngia</a></span>, </li>
   <li><span class="hlFld-ContribAuthor"><a href="/action/doSearch?ContribAuthorRaw=Shoham%2C+Menachem" title="Menachem Shoham">Menachem Shoham</a></span>, </li>
   <li><span class="hlFld-ContribAuthor"><a href="/action/doSearch?ContribAuthorRaw=Casey%2C+Joanne+L" title="Joanne L. Casey">Joanne L. Casey</a></span>, </li>
   <li><span class="hlFld-ContribAuthor"><a href="/action/doSearch?ContribAuthorRaw=Foley%2C+Michael" title="Michael Foley">Michael Foley</a></span>, </li>
   <li><span class="hlFld-ContribAuthor"><a href="/action/doSearch?ContribAuthorRaw=Adams%2C+John+H" title="John H. Adams">John H. Adams</a></span>, </li>
   <li><span class="hlFld-ContribAuthor"><a href="/action/doSearch?ContribAuthorRaw=King%2C+Christopher+L" title="Christopher L. King">Christopher L. King</a></span></li>
</ul>
</li></ul></section>
</div><div id="pane-3c1dc793-20ba-4336-a3d4-bb86a6fc2c4311" aria-labelledby="pane-3c1dc793-20ba-4336-a3d4-bb86a6fc2c4311con" role="tabpanel" class="tab__pane">



        
        <!--content loaded via ajax-->
<div class="asmj-org general-rss-feed-reader aog" id="80036a5d-0f41-4828-9cd1-19399fe2560a" data-rss-url="https://asm.org/rss/content/">
    <div class="rss-body"></div>
</div>
</div></div></div>

        </div>
    
</div>

        </div>
    




        
        
</div>
</main>




        
        <footer class="footer"><div class="footer__wrapper container container--lg"><div class="footer__top row"><div class="sitemap"><div class="sitemap__column sitemap__column--media col-xs-12"><div class="footer__logos">



        
        <a href="https://asm.org/" title="American Society for Microbiology logo"><img id="" alt="American Society for Microbiology logo" src="/specs/products/asmj/releasedAssets/images/asm-white.svg"/></a>




        
        <a href="/" title="ASM Journals logo"><img id="" alt="ASM Journals logo" src="/specs/products/asmj/releasedAssets/images/asm-logotype.svg"/></a>
</div><div class="footer__social-media">



        
        <div class="footer__social-media">
    <ul class="rlist--inline">
        <li><a href="https://www.facebook.com/asmfan" target="_blank" rel="noopener"><i class="icon-facebook"></i></a></li>
        <li><a href="https://twitter.com/asmicrobiology" target="_blank" rel="noopener"><i class="icon-twitter"></i></a></li>
        <li><a href="https://www.linkedin.com/companies/45861" target="_blank" rel="noopener"><i class="icon-linkedin"></i></a></li>
        <li><a href="https://www.youtube.com/channel/UCBxWzf49gVHz0Ksgw_N8brw" target="_blank" rel="noopener"><i class="icon-youtube"></i></a></li>
    </ul>
</div>
</div></div><div class="sitemap__column sitemap__column--journals col-xs-12">



        
        <a href="#" data-toggle-target-id="footerJournals"><h6 class="footer__list-title">JOURNALS</h6></a>
<ul id="footerJournals" class="rlist footer__list footer__list--columns">
	<li><a href="/journal/aac">Antimicrobial Agents and Chemotherapy</a></li>
	<li><a href="/journal/aem">Applied and Environmental Microbiology</a></li>
	<li><a href="/journal/cvi">Clinical and Vaccine Immunology</a></li>
	<li><a href="/journal/cmr">Clinical Microbiology Reviews</a></li>
	<li><a href="/journal/ecosalplus">EcoSal Plus</a></li>
	<li><a href="/journal/ec">Eukaryotic Cell</a></li>
	<li><a href="/journal/iai">Infection and Immunity</a></li>
	<li><a href="/journal/jb">Journal of Bacteriology</a></li>
	<li><a href="/journal/jcm">Journal of Clinical Microbiology</a></li>
	<li><a href="/journal/jmbe">Journal of Microbiology &amp; Biology Education</a></li>
	<li><a href="/journal/jvi">Journal of Virology</a></li>
	<li><a href="/journal/mbio">mBio</a></li>
	<li><a href="/journal/mmbr">Microbiology and Molecular Biology Reviews</a></li>
	<li><a href="/journal/mra">Microbiology Resource Announcements</a></li>
	<li><a href="/journal/spectrum">Microbiology Spectrum</a></li>
	<li><a href="/journal/mcb">Molecular and Cellular Biology</a></li>
	<li><a href="/journal/msphere">mSphere</a></li>
	<li><a href="/journal/msystems">mSystems</a></li>
</ul>
</div><div class="sitemap__column sitemap__column--connect col-xs-12">



        
        <ul class="rlist footer__list">
    <li><h6>RESOURCES</h6></li>
    <li><a href="/about-asm-journals" target="_blank" rel="noopener">About Us</a></li>
    <li><a href="/announcements" target="_blank" rel="noopener">Announcements</a></li>
    <li><a href="/asm-author-center" target="_blank" rel="noopener">Author Center</a></li>
    <li><a href="/collection" target="_blank" rel="noopener">ASM Journal Collections</a></li>
     <li><a href="/publishing-ethics" target="_blank" rel="noopener">Publishing Ethics</a></li>
    <li><a href="/migration-information" target="_blank" rel="noopener">Migration Information</a></li>
    <li><a href="/advertising" target="_blank" rel="noopener">Advertising</a></li>
    <li><a href="https://asm.org/Membership/Home" target="_blank" rel="noopener">ASM Membership</a></li>
    <li><a href="https://asm.org/cookie-policy" target="_blank" rel="noopener">Privacy Policy</a></li>
    <li><a href="/terms" target="_blank" rel="noopener">Terms &amp; Conditions</a></li>
    <li><a href="/proprietary-rights" target="_blank" rel="noopener">Proprietary Rights Notices</a></li>
    <li><a href="/non-commercial-tdm-license" target="_blank" rel="noopener">Non-Commercial TDM License</a></li>
</ul>
</div><div class="sitemap__column sitemap__column--news col-xs-12">



        
        <a href="#" data-toggle-target-id="footerConnected"><h6 class="footer__list-title">STAY CONNECTED</h6></a>
<ul id="footerConnected" class="rlist footer__list">
    <li><a href="/action/showPreferences?menuTab=Alerts" target="_blank" rel="noopener">Alerts</a></li>
    <li><a href="/asm-journals-rss-feeds" target="_blank" rel="noopener">RSS Feeds</a></li>
    <li><a href="/contact-us" target="_blank" rel="noopener">Contact Us</a></li>
    <li><a href=" https://connect.asm.org/ " target="_blank" rel="noopener">ASM Communities</a></li>
    
</ul>
</div><div class="sitemap__column sitemap__column--other col-xs-12 ">



        
        <h6>NEWS</h6>
<ul class="rlist footer__list">
    <li><a href="https://asm.org/newsroom" target="_blank" rel="noopener">Press Releases</a></li>
    <li><a href="https://asm.org/Browse-By-Content-Type/Policy-Statement" target="_blank" rel="noopener">Policy Statements</a></li>
    
</ul>
</div></div></div><div class="footer__bottom row"><div class="col-xs-12"><div class="footer__copyright">



        
        Copyright Â© 2022 American Society for Microbiology
</div></div></div></div></footer>




        
        <div class="cookiePolicy-popup"><div class="container"><div class="row"><div class="col-sm-7 col-md-9 cookiePolicy-popup__content"><span><span><strong>American Society for Microbiology ("ASM")</strong> is committed to maintaining your confidence and trust with respect to the information we collect from you on websites owned and operated by <strong>ASM ("ASM Web Sites")</strong> and other sources. This Privacy Policy sets forth the information we collect about you, how we use this information and the choices you have about how we use such information.</span></span></div><div class="col-sm-5 col-md-3"><div class="cookiePolicy-popup__actions"><button id="accept-cookie-policy" class="btn btn-primary btn--borderless">ACCEPT &nbsp;<span class="sr-only">the cookie policy and </span><span aria-hidden="true">& &nbsp;</span>CONTINUE</button><a href="https://asm.org/cookie-policy" class="btn btn-secondary btn--darker-content">FIND OUT MORE <span class="sr-only">about the privacy policy</span></a></div></div></div></div></div>
</div>
        </div>
    </div>



        
        

            <script src="/products/asmj/releasedAssets/js/build.lazyload.bundle-9eae693cc49bd405a4bc.js"></script>

        <script src="/products/asmj/releasedAssets/js/main.bundle-f0f6c9d7da4e7fd5b03e.js" ></script>
        

















<script defer src="https://static.cloudflareinsights.com/beacon.min.js/v652eace1692a40cfa3763df669d7439c1639079717194" integrity="sha512-Gi7xpJR8tSkrpF7aordPZQlW2DLtzUlZcumS8dMQjwDHEnw9I7ZLyiOj/6tZStRBGtGgN6ceN6cMH8z7etPGlw==" data-cf-beacon='{"rayId":"6e7ac21cab8f7ba4","token":"edc08be6f1e64730992376d7e16c0615","version":"2021.12.0","si":100}' crossorigin="anonymous"></script>
</body>
</html>
